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Gram-negative bacteria enhance their survival in harmful environments by outer 
membrane remodeling, particularly at the lipid A moiety of LPS.  We recently identified 
a functional ortholog of the lipid A kinase, lpxT, in Pseudomonas aeruginosa.  LpxTPa is 
unique from previously characterized LpxT enzymes in that it is able to phosphorylate 
both lipid A phosphate groups as well as generate a novel 1-triphosphate species. Low 
Mg2+ results in modulation of LpxTPa activity and is influenced by transcription of lipid 
A aminoarabinose (L-Ara4N) transferase ArnT, which is induced when Mg2+ is limiting 
(Nowicki et al., Mol Micro, 2014).  We have also revealed the identity of a functional 
phosphoethanolamine (pEtN) transferase, EptAPa, in P. aeruginosa, and the first report of 
pEtN-modified lipid A in this organism.  EptAPa adds pEtN strictly to the non-canonical 
position of lipid A. Transcription of eptAPa is regulated by Zn2+ via the ColRS two-
component system, contrasting from EptA regulation in enteric bacteria such as 
Salmonella enterica and Escherichia coli.  Further, although L-Ara4N modification 
readily occurs at the same site of pEtN addition under several environmental conditions, 
Zn2+exclusively induces pEtN addition to lipid A and downregulates transcription of the 
L-Ara4N transferase gene (Nowicki et al., Mol Micro, 2015).  The existence and 
specificity of these modification enzymes suggests that coordinated regulation of P. 
aeruginosa outer membrane remodeling occurs to permit adaptation to a changing 
environment. 
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Chapter 1:  Introduction 
1.1     THE GRAM-NEGATIVE BACTERIAL CELL ENVELOPE:  A PROTECTIVE BARRIER 
1.1.1   Structure and properties of the Gram-negative cell envelope 
The bacterial cell envelope is a complex, dynamic structure that serves as a 
protective barrier against perturbations in the surrounding environment.  The defining 
feature of Gram-negative bacteria is their cell envelope structure which consists of two 
lipid bilayers. While the Gram-negative inner membrane is composed entirely of 
phospholipids in both leaflets of the bilayer, the outer membrane is asymmetrical with 
phospholipids forming the inner leaflet, and lipopolysaccharide the outer leaflet (Fig. 
1.1A)(1).  Divalent cations such as Mg2+ and Ca2+ intercalate between LPS molecules to 
help stabilize the outer membrane (2).  The outer membrane is the first line of bacterial 
defense against environmental stressors, serving as a protective barrier to prevent binding 
and uptake of toxic molecules such as cationic antimicrobial peptides (CAMPs) (2).   
Study of bacterial surface structure and its impact on cell survival in potentially 
deleterious conditions is critical in order to understand an organism’s ability to adapt and 
persist. 
The major component of the outer membrane, lipopolysaccharide, interfaces with 
the environment and can be remodeled as the cell’s surroundings change to offer the 
bacterium greater protection against harmful conditions.  Lipopolysaccharide is 
composed of three distinct domains:  a lipid A anchor, a core sugar region, and an outer 
polysaccharide known as O-antigen (Fig. 1.1A)(1).  Lipid A is first synthesized through 
the conserved nine enzyme Raetz pathway.  The resulting molecule has a β-1',6-linked 
di-glucosamine backbone that is phosphorylated on either side as well as fatty acylated 
(Fig. 1.1B).  After lipid A is synthesized, a short chain of sugars is added at the inner   
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Figure 1.1: Structures of the Gram negative cell envelope and the lipid A region of LPS. 
 
A)  Diagram of the Gram-negative cell envelope; the cytoplasm (C), inner membrane 
(IM), periplasm (P), and outer membrane (OM) are depicted along with membrane 
proteins as indicated.  The lipid A, core, and O-antigen domains of lipopolysaccharide 
(LPS), which forms the outer leaflet of the outer membrane, are indicated.  B)  Structure 
of the canonical hexa-acylated, bis-phosphorylated lipid A in E. coli synthesized via the 
Raetz pathway.  Addition of a second phosphate group at the 1-position by the kinase 
LpxT, which composes approximate one-third of E. coli lipid A species in standard 
laboratory growth media, is indicated in red. 
 
  
A B 
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leaflet of the inner membrane, forming the core.  The core region is often substituted with 
non-sugar residues, such as amino acids, phosphate groups, or ethanolamine moieties that 
can impact surface charge and antimicrobial resistance (3).  After its synthesis, lipid A-
core is then flipped to the periplasmic face of the inner membrane by the MsbA 
transporter, and O-antigen is subsequently conjugated to the molecule (1).  O-antigen 
consists of a long chain of repeating sugar subunits, and varies greatly between species 
and even strains within the same species.  Due to this great variability and strain-specific 
interaction with antibodies, O-antigen is used to serotype bacterial strains (3). 
Although core and O-antigen regions of LPS are undoubtedly critical for host 
infection, the majority of LPS immunostimulatory activity is due to lipid A.  The lipid A 
domain is often referred to as endotoxin as it is a potent activator of the innate immune 
system (4). Mammalian cells contain Toll-like receptor 4 (TLR-4), a pattern recognition 
receptor that binds to bacterial lipid A along with the help of LPS binding protein and the 
co-receptors myeloid-differentiation factor 2 (MD-2) and CD14 (5).  Binding initiates a 
downstream, pro-inflammatory signaling cascade culminating in the production of NF-
κB, which then induces genes that promote clearance of the pathogen (2, 6).  Resulting 
products include cytokines, CAMPs, and immunostimulatory molecules (7).  Although 
the immunostimulatory properties of lipid A can lead to bacterial clearance, 
overwhelming amounts of endotoxin in the system can lead to septic shock, characterized 
by capillary leakage, hypotension and vascular coagulation that leads to multiple organ 
failure and in some cases death (7–9).  In addition to its role in activating the immune 
system, lipid A is also the prime target of CAMPs and alterations in divalent cation 
concentrations that can disrupt the outer membrane and cause lysis (2, 10).  Although 
interactions with the host immune system and antimicrobial peptides are extremely 
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harmful for bacteria, Gram-negatives have evolved a number of strategies to modify their 
lipid A structure to promote their survival (2).  
 
1.1.2   The importance of studying lipid A in the opportunistic pathogen, 
Pseudomonas aeruginosa 
Pseudomonas aeruginosa inhabits soil and water sources and is known for its 
intrinsic tolerance to antimicrobials and potentially toxic contaminants such as heavy 
metals (11, 12).  It is also a formidable opportunistic pathogen frequently acquired in 
healthcare facilities due to its persistence in sinks, showers and many non-aquatic abiotic 
surfaces (11, 13, 14).  Once inside a human host P. aeruginosa thrives in a variety of 
tissue types resulting in acute skin, eye, and burn wound infections (13).  Perhaps most 
notably, however, are chronic P. aeruginosa infections that persist within the lungs of 
cystic fibrosis (CF) patients for years and are recalcitrant to most antimicrobial treatment 
(11, 15).  CF disease is genetically characterized by extensive mutation of the 
transmembrane conductance regulator or CFTR gene that encodes a chloride channel.  
Mutation of this gene results in malfunction of the channel and causes abnormalities in 
airway surface fluid.  Ultimately, this leads to a reduced ability to clear inhaled microbes.  
Pseudomonas aeruginosa has specific affinity for the CF lung and adapts to thrive in the 
respiratory mucosa (16, 17).   
Due to its adaptability, P. aeruginosa infections are extremely difficult to treat 
and are often debilitating or even fatal (13).  The dynamic outer membrane of Gram-
negatives like P. aeruginosa is a major contributor to its persistence, and the ability to 
remodel lipid A is one facet of this.  Although a hexa-acylated lipid A is initially 
synthesized in P. aeruginosa as in enteric bacteria (Fig. 1.2A), specific lipid A structures 
are found in P. aerugionsa depending on the source of the isolate.  The lipid A   
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Figure 1.2: P. aeruginosa lipid A structure with and without modifications.   
 
A)  Canonical, hexa-acylated, bis-phosphorylated lipid A structure is shown in black.  
Phosphorylation of the lipid A phosphate groups by the LpxT kinase, which occurs in 
standard growth media, is indicated in brown.  B) Possible modifications to P. 
aeruginosa lipid A are indicated in color, including addition of a palmitate chain by PagP 
(green), removal of the 3-hydroxydecanoate acyl chain by PagL (pink), hydroxylation of 
the C12 secondary acyl chain(s) by LpxO (orange), addition of L-Ara4N at the lipid A 
phosphate groups by ArnT (blue), and pEtN addition by EptA (red).  
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acylation pattern characteristic of P. aeruginosa from chronic CF lung and airway 
infections is a stronger TLR-4 stimulant than the lipid A typically found associated with 
acute infection or environmental isolates.  This toxicity significantly contributes to lung 
damage, one of the hallmarks of CF disease that leads to worsened patient prognosis (6).  
Other modifications to P. aeruginosa lipid A lead to greater antimicrobial resistance, 
another characteristic attribute of Pseudomonas (18, 19).  Chapters 2 and 3 will provide a 
detailed analysis of two previously uncharacterized P. aeruginosa lipid A modification 
enzymes, and provide evidence that various lipid A modification enzymes in this 
organism are precisely coordinated in response to specific environmental conditions.  
Since P. aeruginosa lipid A remodeling has been previously shown to play an important 
role in this organism’s virulence, examination of these new modifications and their 
potential biological role could add significant value toward our understanding of 
Pseudomonas infection. 
1.2     LIPID A MODIFICATIONS 
The product of the Raetz pathway is a hexa-acylated, bis-phosphorylated lipid A 
molecule as shown for the model organism Escherichia coli (Fig. 1.1B) and for P. 
aeruginosa (Fig.1.2A).  Although this hexa-acylated lipid A is initially synthesized in 
nearly all Gram-negatives, elaborate lipid A modification systems exist that are 
responsible for the diversity of lipid A molecules produced by different bacterial species 
(1, 2).  Changes can be made to the acylation pattern of lipid A, as well as to the lipid A 
phosphate groups.  While some of these modifications occur constitutively in certain 
bacterial species, others occur exclusively in response to specific environmental 
conditions and are tightly regulated.   
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1.2.1    Acyl chain modifications and effects 
Alterations to the lipid A acyl chains can affect the toxicity of lipid A, as well as 
bacterial resistance to CAMPs.  One such change is the addition of a palmitate (C16:0) 
acyl chain via the enzyme PagP in organisms including E. coli, S. enterica and P. 
aeruginosa (Fig. 1.2B) (19, 20).  Palmitate is cleaved from phospholipids in the outer 
leaflet of the outer membrane, allowing the cell to reduce the phospholipid content while 
simultaneously modifying the lipid A structure (20).  PagP is an outer membrane β-barrel 
protein with its active site at the outer surface of the cell (21).  Transcription of pagP is 
induced under conditions that compromise outer membrane integrity and increase the 
phospholipid content in the outer leaflet, such as limiting Mg2+ concentration (20, 21). 
Lipid A palmitoylation has been shown to provide resistance to certain CAMPs including 
the synthetic α-helical peptide C18G generated from human platelet factor IV (19, 22).  
The altered packing of acyl chains is thought to affect movement of the peptide through 
the membrane (22).  Additionally, the hepta-acylated lipid A generated by palmitate 
addition in E. coli and S. enterica is significantly reduced in toxicity and is unable to 
induce production of the inflammatory mediators TNFα and NF-κB (23). 
Removal of an acyl chain can also occur via the outer membrane β-barrel lipase, 
PagL, in organisms including P. aeruginosa and S. enterica (2, 24).  In P. aeruginosa, 
this enzyme removes the hydroxydecanoate acyl chain at the 3 position (Fig. 1.2B) (7, 
25).  While removal of this acyl chain has no effect on CAMP resistance, it does affect 
TLR-4 stimulation.  Deacylated lipid A purified from E. coli expressing S. enterica PagL 
showed a 30-100 fold decrease in TLR-4 stimulation compared to unmodified, hexa-
acylated lipid A (26).  Penta-acylated lipid A species characteristic of P. aeruginosa 
laboratory, acute infection, and environmental isolates are also far less stimulatory than 
hexa-acylated species commonly found within the CF airway (6).  
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One last alteration that can be made to lipid A acyl chains in organisms such as S. 
enterica and P. aeruginosa is hydroxylation by the enzyme LpxO.  A single, inner 
membrane LpxO enzyme exists in S. enterica that transfers a hydroxyl group to the 2-
position acyl chain (27).  In P. aeruginosa, two LpxO enzymes exist that hydroxylate 
each of the secondary lauryl chains (Fig. 1.2B) (3).  LpxO activity is oxygen-dependent, 
and although active under normal laboratory conditions in both organisms, it can also be 
induced when Mg2+ concentration is limiting in S. enterica (28). LpxO enzymes in P. 
aeruginosa have yet to be fully characterized, and the biological role of this modification 
remains a mystery.  A study in S. enterica however has revealed that in this organism 
LpxO, along with the virulence and stress-related periplasmic protein VisP, has a key role 
in pathogenesis.  Without LpxO, S. enterica cells exhibit decreased survival within 
macrophages and virulence within a murine in vivo systemic infection model (29). 
 
1.2.2    Phosphate group modifications and effects 
 
The phosphate groups of lipid A can be modified with several different moieties, 
which can alter the net charge of the membrane and affect its stability.  In E. coli, the 
outer membrane kinase LpxT transfers a phosphate group from undecaprenyl 
pyrophosphate (Und-PP) strictly to the 1-phosphate group of lipid A.  This results in 
regeneration of undecaprenyl phosphate (Und-P), an important precursor involved in the 
biosynthesis of bacterial membrane components, while simultaneously forming tris-
phosphorylated (1-diphosphate) lipid A (30).  Tris-phosphorylated lipid A composes 
approximately one-third of E. coli lipid A grown in standard laboratory conditions, thus 
this modification does not seem to require any particular inducing condition (Fig. 1.1B) 
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(30).  Recently, we identified an LpxT ortholog in P. aeruginosa that unlike E. coli LpxT, 
can modify either the 1 or the 4ʹ′ phosphate groups under normal growth conditions (Fig. 
1.2A).  We also found that P. aeruginosa LpxT can add a third phosphate group to the 1 
position resulting in a unique 1-triphosphate species, although this lipid A species has 
only been seen in the absence of the 4ʹ′ phosphate group (31).  The characterization of 
LpxT will be described in further detail in Chapter 2. 
Positively charged moieties can also be added to mask the anionic phosphate 
groups of lipid A.  This serves to increase resistance to CAMPs, as these positively 
charged peptides act by binding to the lipid A phosphate groups to mediate their entry 
into the cell, thereby displacing the stabilizing Mg2+ and Ca2+ ions (32).  The inner 
membrane enzyme ArnT transfers the cationic sugar 4-amino-4-deoxy-L-arabinose (L-
Ara4N) to the 1- and 4'-phosphate groups of E. coli, S. enterica, and P. aeruginosa lipid 
A, to name a few examples (Fig. 1.2B) (33–35).  Transfer occurs in the periplasm using 
the lipid undecaprenyl phosphate-α-L-Ara4N as a donor (36).  The arnT gene, formerly 
known as pmrK, is part of the pmrHFIJKLM operon that along with the unlinked pmrE 
locus together are involved in the biosynthesis and addition of L-Ara4N to lipid A (37).  
Substitution of L-Ara4N at one or both lipid A phosphate groups is known to be an 
important modification for CAMP resistance (38), and is characteristic of constitutively 
resistant strains (39). 
Another positively charged group, phosphoethanolamine (pEtN), is added 
preferentially (or exclusively) to the lipid A 1-phosphate group by the inner membrane 
pEtN transferase, EptA, in a number of Gram-negatives including E. coli, S. enterica and 
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Helicobacter pylori (2, 40, 41).  While pEtN addition plays a more minor role in CAMP 
resistance in E. coli and Salmonella enterica (40, 42, 43), pEtN modification of H. pylori 
lipid A results in a dramatic increase in resistance to the cyclic CAMP polymyxin (44).  
Mutants of the eptA ortholog, eptC, in Campylobacter jejuni have a significant 
colonization defect in both chick and mouse infection models, and are drastically reduced 
in motility (45, 46).  In addition to modifying lipid A, EptC transfers pEtN to the flagellar 
rod protein FlgG; this modification is necessary for proper assembly of the flagellum and 
thus motility in C. jejuni (46).  Further, Neisseria gonorrhoeae unable to modify lipid A 
with pEtN demonstrates a marked fitness advantage in both mice and human infection 
(47). We have recently identified a functional EptA enzyme in P. aeruginosa that strictly 
modifies lipid A at the 4' phosphate group (Fig. 1.2B)(48).  This modification is 
described in detail in Chapter 3. 
In organisms such as Fransicella novicida (an environmental strain related to the 
pathogen F. tularensis) and H. pylori, the lipid A phosphate groups can be removed 
entirely by the action of the inner membrane phosphatases LpxE and LpxF.  LpxE 
selectively cleaves the lipid A 1-phosphate group (41, 49), while LpxF targets the 4ʹ′ 
phosphate group (50, 51).  In F. novicida, LpxF has been shown to have additional 
specificity for tetra- and penta-acylated lipid A substrates (50). Removal of either 
phosphate group reduces the ability of lipid A to activate TLR-4 by a factor of 103 (52).  
In addition to decreasing the toxicity of lipid A, removal of either or both phosphate 
groups also results in a drastic increase in polymyxin resistance, with 4ʹ′ 
dephosphorylated lipid A showing greater resistance than the 1-dephosphorylated species 
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(50, 51).  Removal of the 1-phosphate group of H. pylori by LpxE is also a requirement 
for pEtN addition to lipid A, and significantly increases polymyxin resistance (41, 44).  
Further, removal of either or both phosphate groups is critical for H. pylori colonization 
of gastric mucosa, as LpxE, LpxF or double mutants are impaired in host colonization in 
a murine model (51). 
1.2.3  Lipid A phenotypes characteristic of acute and chronic P. aeruginosa 
infections 
 
While many of the lipid A modifications described thus far often only occur in 
response to specific environmental cues, P. aerugionsa lipid A from CF infection isolates 
commonly has constitutive modifications (15).  Studies comparing lipid A from chronic 
CF infection isolates to those from patients with acute conditions (such as bronchiectasis, 
blood, ear or urinary tract infections), environmental isolates, or laboratory-adapted 
strains identified CF-specific lipid A species.  CF lipid A contains palmitate and often L-
Ara4N, modifications that are normally regulated and typically only found during 
specific environmental conditions (i.e. low Mg2+, subinhibitory CAMP concentrations) 
(Fig. 1.3) (34).  Further, approximately one-third of P. aeruginosa lipid A isolated from 
CF patients, particularly from adults with severe lung disease, showed loss of PagL 
activity, and is thus hexa-acylated (25, 53). Modification of this hexa-acylated lipid A 
with a palmitate chain results in a unique, hepta-acylated structure (6). Environmental 
and acute infection isolates on the other hand are generally penta-acylated and were not 
found to contain palmitate or L-Ara4N medication (Fig. 1.3) (53).  
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Figure 1.3: Lipid A structures characteristic of P. aeruginosa strains isolated from 
different source.   
 
The penta-acylated, bis or tris-phosphorylated lipid A structure most often found in 
laboratory-adapted, environmental, and acute infection isolates of P. aeruginosa is 
depicted on the left side.  Phosphorylation by the kinase LpxT (brown) is shown.  On the 
right, the hexa- and hepta-acylated lipid A structures commonly found in CF infection 
isolates are shown.  CF infection isolates are often modified with an additional palmitate 
acyl chain (green), and L-Ara4N moieties (blue), as indicated.  
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The lipid A structure characteristic of P. aeruginosa CF isolates has been shown to 
promote inflammation and CAMP resistance within the lung. The palmitoylated, hexa-
acylated lipid A typical of P. aeruginosa CF isolates is highly immunostimulatory and 
reacts strongly with TLR-4.  In contrast the penta-acylated lipid A structure of P. 
aeruginosa laboratory, environmental, and acute infection isolates can be >100-fold less 
stimulatory (6, 34).  Lipid A isolated from P. aeruginosa CF strains also shows 
significant enhancement in the production of IL-8, an inflammatory mediator whose 
production contributes to increased lung inflammation and damage (34).  In addition to 
the affect on toxicity, CF-specific lipid A species are also innately more resistant to 
CAMPs due to their modification with L-Ara4N and palmitate.  Many CF isolates have 
been found to be highly resistant to colistin (also known as polymyxin E), a cyclic CAMP 
that is commonly used as a second line treatment of CF bacterial infections (54).  The 
lipid A of these highly resistant strains is consistently modified with L-Ara4N and often 
palmitate, highlighting the clinical importance of lipid A remodeling (53).   
 
1.3     REGULATION OF LIPID A MODIFICATIONS 
1.3.1 Transcriptional Regulation 
 
Transcription of lipid A modification enzymes is often induced through two-
component system signaling (2).  Signal transduction occurs when a bacterial sensor 
kinase autophosphorylates in response to an external stimulus and then transfers this 
phosphate group to a response regulator protein.  The resulting conformation in the 
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response regulator promotes DNA binding at target promoters to alter gene expression 
(55).  Response regulators can also be dephosphorylated by their cognate sensor kinases 
allowing further control over gene expression (56).  The systems and mechanisms 
responsible for regulation of lipid A modification are best understood in the model 
organisms E. coli and S. enterica.  In both of these organisms, the PhoPQ system 
regulates pagP transcription in response to low Mg2+ concentration as well as 
subinhibitory CAMP concentrations (20).  In S. enterica, pagL transcription is also 
activated in a PhoPQ-dependent manner (7).  In addition to pagP and pagL, the PhoPQ 
system induces LpxO-mediated hydroxylation of S. enterica lipid A, although this 
modification can occur at a basal level even in standard growth conditions (28)(Fig. 1.4).   
A second two-component system, PmrAB, regulates transcription of arnT and 
eptA in both E. coli and S. enterica (42).  In these organisms, PmrAB is activated in 
response to mildly acidic pH (57), excess ferric iron (58, 59), and other conditions that 
are not as well characterized including excess Al3+ (60) and Zn2+ (61) (Fig. 1.4).  In 
addition to activation of PmrAB upon sensing these signals, this system can also be 
indirectly activated when the PhoPQ system is induced in both S. enterica and E. coli (62, 
63).  This connection of PhoPQ and PmrAB is possible via the action of the PmrD 
protein (62).  PmrD interacts post-transcriptionally with PmrA and prevents its 
dephosphorylation to keep it active (Fig. 1.4) (62, 64). 
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Figure 1.4: Transcriptional regulation of S. enterica lipid A modifications by the PhoPQ 
and PmrAB two-component systems. 
 
In S. enterica, the PhoPQ two-component system responds to limiting Mg2+ as well as 
subinhibitory concentrations of CAMPs.  This system induces expression of the pagL and 
pagP lipid A modification genes, as well as activating transcription of the PmrD protein.  
PmrD interacts with PmrA, keeping it phosphorylated and thus activated even when the 
PmrAB system is not activated.  Through this PmrD connector protein, PmrA can 
activate transcription of arnT and eptA when Mg2+ is limiting or when CAMPs are 
present.  The PmrAB system can also activate arnT and eptA gene expression 
independently of PhoPQ, in response to a variety of environmental stimuli including mild 
acidic pH and excess Fe3+.   
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The two well-conserved two-component systems PhoPQ and PmrAB also play a 
major role in modulating lipid A modification gene expression in P. aeruginosa, although 
there are a few notable differences between P. aeruginosa and the model organisms 
discussed.  While the PhoQ sensor of S. enterica can both activate and repress PhoP 
activity by phosphorylation or dephosphorylation, respectively, P. aeruginosa PhoQ 
might play a greater role in repressing PhoP activity (65).  Although not yet determined, 
it is plausible that a second kinase capable of activating PhoP under Mg2+ limitation 
exists (65, 66). The PhoP response regulator activates pagP and arnT transcription in 
response to limiting Mg2+ (Fig. 1.5)(19, 67).  In P. aeruginosa, arnT transcription can 
also be induced by the PmrAB system upon sensing either limiting Mg2+ or subinhibitory 
CAMP concentrations (Fig. 1.5) (67, 68).  Although P. aeruginosa PagL is constitutively 
active in both laboratory strains and many CF isolates of P. aeruginosa, its activity in 
acute clinical and environmental isolates can be enhanced in the presence of limiting 
Mg2+ (25).  It is possible that either the PhoPQ or PmrAB systems are involved in 
regulating pagL transcription, although this has never been shown.  To date, whether or 
not a connection exists between the PhoPQ and PmrAB systems in P. aeruginosa remains 
to be determined. 
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Figure 1.5: Transcriptional regulation of P. aerugionosa lipid A modifications by the 
PhoPQ and PmrAB two-component systems. 
 
The P. aeruginosa PhoPQ two-component system, which responds to limiting Mg2+, 
activates transcription of the lipid A modification genes pagP and arnT.  Transcription of 
arnT is also activated by the PmrAB system independently of PhoPQ in response to 
limiting Mg2+ as well as various CAMPs, including polymyxin.  
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Aside from PhoPQ and PmrAB, three additional two-component systems are 
involved in lipid A modification and polymyxin resistance in P. aeruginosa (Fig. 1.6).  
The first two of these systems, ParRS and CprRS, both activate arnT transcription in 
response to various CAMPs (69, 70).  Microarray-based transcriptional analysis also 
indicates that ParRS induces transcription of pagL, although this has not yet been 
experimentally confirmed (70). The third system, ColRS, remains largely unstudied in P. 
aeruginosa but plays a role in heavy metal tolerance and overall membrane stability in P. 
putida and P. fluorescens (71–73).  A recent study investigated the role of CprRS and 
ColRS in P. aeruginosa polymyxin resistance. This report revealed that these systems can 
promote polymyxin resistance in a highly resistant ΔphoQ strain and also suggested that 
additional unknown factors contribute to polymyxin resistance (54).  Our laboratory has 
now begun to characterize the role of the ColRS system in lipid A modification.  In P. 
aeruginosa, this system responds to Zn2+ and activates the transcription of eptA, which 
adds pEtN groups to lipid A that previously had not been detected in this organism.  
Simultaneously, ColR represses arnT transcription in a Zn2+-dependent manner, exerting 
strict control over which amine-containing modification group will be added to the lipid 
A (Fig. 1.6)(48). Given the complexities of modification systems in P. aeruginosa, 
continued study of lipid A modification, its regulation, and its role in antimicrobial 
resistance are necessary. 
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Figure 1.6: Transcriptional regulation of P. aeruginosa lipid A modifications by the 
ParRS, CprRS, and ColRS two-component systems. 
 
The P. aeruginosa ParRS and CprRS two-component system both respond to CAMPs 
and induce transcription of arnT.  In addition to activating arnT transcription, the ParRS 
system also acts to repress transcription of the lipid A deacylase, pagL.  The P. 
aeruginosa ColRS system senses Zn2+, and activated ColR then induces transcription of 
the pEtN transferase eptA while repressing arnT transcription.  
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1.3.2    Post-transcriptional regulation 
 	   	   In addition to the complex systems in place to regulate the transcription of lipid A 
modification genes, control over the activity of these modification enzymes can also 
occur at the post-translational level.  One example is negative regulation of the lipid A 
kinase, LpxT, upon activation of the PmrAB system.  If an S. enterica or E. coli cell is 
grown in the presence of excess Fe3+, iron is initially taken up by the cell.  Upon 
activation of PmrAB, however, transcription of the short peptide PmrR is induced.  PmrR 
binds to and prevents LpxT from transferring an additional phosphate group to lipid A 
(74).  The very condition that leads to inhibition of LpxT activity, however, induces 
transcription of eptA (42, 58).  Other conditions that either directly or indirectly induce 
eptA transcription, including mild acid pH and limiting Mg2+, also inhibit LpxT activity 
(42). The 1-phosphate group, sole site of phosphorylation by LpxT and primary site of 
pEtN addition, is now open to modification by EptA (42).  The amine-containing pEtN 
moiety reduces the overall negative charge of the outer membrane, helping to prevent 
uptake of Fe3+ (74).  Similarly, LpxT activity in P. aeruginosa is inhibited when Mg2+ is 
limiting, a condition that simultaneously activates arnT transcription (31).  As in S. 
enterica and E. coli, this inhibition of LpxT activity occurs post-transcriptionally (31).  
The regulation of the outer membrane modifications in response to a changing 
environment thus appears to be a common phenomenon among different bacterial 
species.  
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 Modification enzymes acting on the lipid A acyl chains can also be controlled 
post-translationally.  While PagP transcription can be induced by the PhoPQ system 
when Mg2+ is limiting, its activity is also increased under conditions that perturb the outer 
membrane such as EDTA treatment (75).  EDTA causes translocation of phospholipids 
from the inner leaflet of the outer membrane to the outer leaflet.  These phospholipids 
migrate and find themselves adjacent to the PagP active site, which then cleaves the 
phospholipid a modifies lipid A in the process (75).  Temperature can be another 
regulatory factor for lipid A modification enzymes as PagL in P. aeruginosa shows 
reduced activity at low growth temperatures (25, 76).  It is possible that still 
uninvestigated mechanisms of post-translational control exist, thus continued study of 
lipid A modification and regulation in P. aeruginosa and all Gram-negatives is extremely 
important. 
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Chapter 2:  Characterization of Pseudomonas aeruginosa LpxT reveals 
dual positional lipid A kinase activity and coordinated control of outer 
membrane modification1 
2.1   INTRODUCTION 
Structural modification of lipid A is a common adaptive response to environmental 
flux, and is often the downstream result of two-component system activation by specific 
external stimuli (1, 2).  For example, transcription of arnT in P. aeruginosa is primarily 
induced by the two-component systems PhoPQ and PmrAB, although recent studies have 
reported the involvement of additional systems (54, 67).  Both of these systems respond 
to limiting Mg2+, while PmrAB can also sense subinhibitory concentrations of CAMPs 
(67, 68).  In E. coli and S. enterica, EptA competes with LpxT for modification at the 1-
phosphate group (42).  LpxT activity as a lipid A kinase is inhibited in response to 
conditions that induce eptA expression via the two-component system PmrA-PmrB, such 
as limiting magnesium or high iron (42, 58, 77).  Activation of PmrA induces 
transcription of a small regulatory peptide, PmrR, which interacts with LpxT to inhibit its 
activity (74). This leaves the lipid A 1-phosphate group open to pEtN addition by EptA.  
In this way, the bacterial cell can precisely orchestrate and permit the most beneficial 
modifications in response to the surrounding environment (42, 74). 
                                                
1 Large portions of this chapter have been previously published (copyright by John Wiley and Sons, re-used 
with permission).  Nowicki EM, O’Brien JP, Brodbelt JS, Trent MS. 2014. Characterization of P 
seudomonas aeruginosa LpxT reveals dual positional lipid A kinase activity and co-ordinated control of 
outer membrane modification: Identification of P. aeruginosa LpxT. Molecular Microbiology 94:728-741. 
(E.M.N. designed and performed experiments and wrote the manuscript under the supervision of M.S.T.; 
J.P.O. designed and performed the ESI and UVPD-MS experiments under the supervision of J.S.B.). 
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While LpxT has only been characterized in E. coli and S. enterica, tris-
phosphorylated lipid A species have previously been reported in other Gram-negatives 
including Neisseria meningitidis and Yersinia pestis (78–80).  Despite the implication 
that lpxT orthologs are widespread, there remains a lack of studies examining the 
biochemistry and regulation of these orthologs.  Work in E. coli and S. enterica has 
revealed the importance of lpxT regulation to promote the addition of positively charged 
moieties to lipid A; whether such coordinated regulation exists in other Gram-negatives is 
currently unknown (42, 74).  We therefore set out to determine the existence of an LpxT 
ortholog in P. aeruginosa and, if present, how this enzyme is regulated.   
Here we report the identification and characterization of a functional LpxT ortholog 
in P. aeruginosa.  We show that LpxTPa activity is distinct from that of LpxTEc in that it 
can add not only to the 1-phosphate, but the 4'-position as well.  We also describe the first 
reported example of a lipid A 1-triphosphate species.  Further, we demonstrate that while 
phosphate group addition to P. aeruginosa lipid A readily occurs when Mg2+ 
concentration is high, LpxTPa activity is inhibited when Mg2+ is limiting, and instead L-
Ara4N modification occurs via the enzyme ArnT.  Deletion of arnT, however, results in 
partial restoration of LpxTPa activity, suggesting coordinated regulation of modification at 
the lipid A phosphate groups. Further investigation of LpxTPa and how it is regulated will 
allow better understanding of lipid A modification machinery in this important 
opportunistic pathogen. 
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2.2 RESULTS 	  
2.2.1 P. aeruginosa lipid A is modified with an additional phosphate group 	  
Reports of tris-phosphorylated lipid A in several different organisms suggest that 
lpxT-mediated phosphorylation of lipid A is widespread across Gram-negatives (78–80).  
We began our search for an lpxT ortholog in P. aeruginosa by performing a BLAST 
(NCBI) bioinformatics analysis to identify highly similar proteins to K-12 E. coli lpxT 
(lpxTEc). A single candidate with significant similarity, PA14_68620 was identified, 
having 30% sequence identity and an e-value of 1e10-18.   This gene is conserved among 
members of the Pseudomonas genus, according to the Pseudomonas Genome Database 
(81). 
The existence of this ortholog (herein referred to as lpxTPa) prompted us to determine 
whether P. aeruginosa lipid A is modified with an additional phosphate group.  Lipid A 
was isolated from P. aeruginosa grown in MOPS minimal medium supplemented with 
2mM MgSO4 and analyzed by MALDI-TOF mass spectrometry (MS). A MgSO4 
concentration of 2mM was used, as this concentration of divalent cations has been 
reported to occur in the human body (70). Lipid A tris-phosphate was clearly detected for 
both the predominant, penta-acylated species and the less-abundant hexa-acylated 
species, generating major molecular ions at m/z 1525.6 and 1695.7, respectively 
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(predicted [M-H]- at m/z 1525.8 and 1696.0) (Fig. 2.1A and 2.1B).  This result confirms 
that P. aeruginosa lipid A can be tris-phosphorylated.   
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Figure 2.1: P. aeruginosa lipid A is modified with an additional phosphate group.   
 
A) Structures of the predominant penta- and hexa-acylated lipid A species and their exact 
masses are shown, with the corresponding phosphate-modified species shown below.  
Phosphate group addition is highlighted in red.  B) MALDI-TOF MS analysis of the 
480mM ammonium acetate lipid A eluate isolated from P. aeruginosa grown in 1 L 
MOPS minimal medium supplemented with 2 mM MgSO4 shows penta- and hexa-
acylated lipid A species (m/z at 1445.6 and 1615.7, respectively) as well as penta- and 
hexa-acylated lipid A tris-phosphate (m/z at 1525.6 and 1695.7, respectively; red). 
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2.2.2 Identification of a functional LpxT ortholog in P. aeruginosa  	  
Given that P. aeruginosa lipid A can be modified with an additional phosphate 
group, the next goal was to determine whether lpxTPa (PA14_68620) is the enzyme 
responsible for this modification.  lpxTPa was expressed in trans in an E. coli lpxT mutant 
(W3110ΔlpxTEc), and 32Pi-labelled lipid A from this strain was isolated and separated by 
TLC.  The migration of E. coli lipid A in our TLC solvent system has been well-
characterized, and consists of two major species: approximately two-thirds bis-
phosphorylated lipid A, and one-third tris-phosphorylated lipid A (lipid A 1-diphosphate) 
due to LpxTEc activity (Fig. 2.2A, lane 1) (42).  Deletion of lpxTEc results in a single, bis-
phosphorylated lipid A species (Fig. 2.2A, lane 2).  Both lpxTEc and lpxTPa were able to 
complement the lpxTEc mutant, as shown by the restoration of the lipid A tris-phosphate 
species (Fig. 2.2A, lanes 3 and 4). LpxTPa activity was confirmed by MALDI-TOF mass 
spectrometry, in which lpxTPa-dependent phosphorylation of lipid A corresponds to the 
peak at m/z 1876.3 (predicted [M-H]- at m/z 1876.2) (Fig. 2.2B & 2.2C).   
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Figure 2.2: Heterologous expression of the P. aeruginosa lpxT ortholog restores tris-
phosphorylated lipid A species in an E. coli  W3110ΔlpxT mutant.    
 
A) Cells were grown in LB medium.  Major 32P-labelled lipid A species are indicated 
with a cartoon of the corresponding structure; colors of groups added to the lipid A 
molecule correspond to colors used in Fig. 1.  Wild-type E. coli W3110 lipid A is isolated 
as two major species, two-thirds bis-phosphorylated lipid A with phosphates at the 1 and 
4’ positions, and one-third tris-phosphorylated lipid A, or lipid A 1-diphosphate (Lane 1).  
TLC separation of lipid A shows that lpxTPa , like lpxTEc, can modifiy E. coli lipid A with 
a phosphate group (lanes 3 and 4).  B & C) MALDI-TOF analysis of lipid A isolated 
from W3110ΔlpxT + empty vector (pWSK29) (B) and W3110ΔlpxT + plpxTPa (C) 
demonstrates that lpxTPa can modify E. coli lipid A with an additional phosphate group 
(m/z at 1876.3, red).  
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2.2.3 An lpxTPa deletion mutant cannot phosphorylate lipid A 	  
 The necessity of lpxTPa for phosphate modification of P. aeruginosa lipid A was 
next examined by generating a chromosomal deletion mutant of lpxTPa.  Lipid A from 
32Pi-labelled wild-type, PA14ΔlpxTPa, and complemented mutant strains was isolated 
from cells grown in MOPS minimal medium supplemented with 2 mM MgSO4 and 
separated by TLC.   Deletion of lpxTPa resulted in loss of a major lipid A species 
predicted to be tris-phosphorylated lipid A (Fig. 2.3A, lane 3) that was restored upon 
complementation with lpxTPa (Fig. 2.3A, lane 4). Samples isolated from P. aeruginosa 
grown in rich medium (LB) also showed LpxTPa-dependent phosphorylation of lipid A 
(Fig. 2.4).  The lack of a lipid A tris-phosphate species in the lpxTPa deletion mutant was 
confirmed by MALDI-TOF and ESI-MS (Figs. 2.3B and 2.5).  In the MALDI-TOF 
spectrum of the complemented mutant strain, however, additional peaks corresponding to 
tris-phosphorylated lipid A species were easily detected (Fig. 2.3C).  lpxTPa is thus 
required for phosphate modification of P. aerguinosa lipid A.   
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Figure 2.3: lpxTPa is necessary for phosphorylation of P. aeruginosa lipid A.    
 
A) E. coli was grown in LB, P. aeruginosa was grown in MOPS minimal medium 
supplemented with 2 mM MgSO4.  Minor lipid A species below major P. aeruginosa 
species correspond to hydroxylated forms of lipid A due to LpxO activity.  TLC 
separation of lipid A shows absence of tris-phosphorylated lipid A when lpxTPa is deleted 
(lane 3).  Upon complementation with plpxTPa, lipid A tris-phosphate is restored (lane 4). 
B) MALDI-TOF MS analysis of the 480mM ammonium acetate lipid A eluate isolated 
from PA14ΔlpxTPa grown in 1 L MOPS minimal medium supplemented with 2 mM 
MgSO4 shows no peaks corresponding to tris-phosphorylated lipid A.  C) MALDI-TOF 
MS analysis of the 480mM elution fraction of lipid A reveals that when lpxTPa is 
expressed in trans in the PA14ΔlpxTPa mutant, phosphorylation of both penta- and hexa-
acylated lipid A is restored (m/z at 1525.8 and 1695.8, respectively; red). 
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Figure 2.4: LpxTPa is active in LB medium.    
 
E.coli strain W3110 and P. aeruginosa were grown in LB broth.  Tris-phosphorylated P. 
aeruginosa lipid A is detected when cells are grown in LB medium at 37°C (lane 2).  
When lpxTPa is deleted, the lipid A tris-phosphate species is absent from the TLC plate 
(lane 3).  When this strain is complemented in trans with plpxTPa, the lipid A tris-
phosphate species is restored (lane 4). 
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Figure 2.5: Negative ion mode ESI mass spectrum of P. aeruginosa PA14ΔlpxT.    
 
The mass spectrum showed the presence of wild type penta-acyl lipid A [Exact mass = 
1446.9 Da], wild type lipid A [Exact mass 1617.0 Da], and a PagP hexa-acylated lipid A 
[Exact mass 1685.1 Da].  There was no evidence of lipid A with an additional phosphate 
group.   
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2.2.4 P. aeruginosa and E. coli LpxT have divergent activity  	  
 Previous analysis of tris-phosphorylated E. coli lipid A has detected phosphate 
group addition exclusively at the 1-position (30, 82).  The next approach was to 
determine whether LpxTPa has a similar site-specificity to that of LpxTEc. Lipid A was 
isolated from P. aeruginosa grown in MOPS minimal medium supplemented with 2mM 
MgSO4 and analyzed first by ESI-MS (Fig. 2.6A) and subsequently by ultraviolet 
photodissociation mass spectrometry (UVPD-MS) (Fig. 2.6C), resulting in ions from 
multiple cleavages of the lipid A parent molecules (selected precursor m/z 762.4).  
UVPD-MS analysis showed that unlike in E. coli, phosphate modification of P. 
aeruginosa lipid A can occur both at the 1-phosphate and the 4'-phosphate groups (Figs. 
2.6B and 2.7A & B).  Cleavages generating molecular ions at m/z 718.34, 734.33, and 
806.49 allowed identification of the 1-diphosphate species, while ions at m/z 636.45, 
654.36, 871.46, and 886.45 provided strong evidence for a 4'-diphosphate species (Figs. 
2.6C and 2.7A & B).  Interestingly, a low abundance of lipid A 1-triphosphate was also 
identified (Figs. 2.6B and 2.7C).  UVPD-MS resulted in fragment ions at m/z 256.90 and 
814.30 thus confirming the identity of the 1-triphosphate species (Figs. 2.6C and 2.7C).  
This unique species is especially surprising given that in addition to the 1-position being 
modified with two additional phosphate groups, the 4' phosphate of the glucosamine 
backbone is absent. This not only demonstrates a previously uncharacterized activity of 
LpxT, but also suggests the existence of a lipid A phosphatase in P. aeruginosa, as such 
an enzyme is necessary to cleave the lipid A 4' phosphate (1, 2). 
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Figure 2.6: LpxTPa-dependent phosphorylation of P. aeruginosa lipid A results in 
multiple tris-phosphorylated species.    
 
A) Negative ion mode ESI mass spectrum of PA14 P. aeruginosa revealing a mixture of 
[M-2H]2- lipid A corresponding to wild type penta-acylated lipid A [Exact mass = 1446.9 
Da] and a species corresponding to an addition of one phosphate group [Exact Mass = 
1526.8 Da].   B) A mixture of three distinct lipid A species (1-pyrophosphate, 4ʹ-
pyrophosphate, and 1-triphosphate species ) were identified through the C) UVPD mass 
spectrum of the [M-2H]2- m/z 762.4 from (A).  Key fragment ions corresponding to each 
of the different lipid A types are highlighted in red with the corresponding precursor 
structure assignment while the remaining fragment ions revealed the lipid A acylation 
pattern.  Fragmentation cleavage maps for the identified species are shown in Fig. 2.7 and 
the precursor ion is marked with an asterisk.    
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Figure 2.7: Fragment ion cleavage maps for the (A) 1-pyrophosphate species, (B) 4ʹ-
pyrophosphate species, and (C) 1-triphosphate species upon UVPD of [M-
2H]2- m/z 762.4 (from Fig. 2.6A).  The corresponding UVPD mass 
spectrum is shown in Figure 2.6C.  
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2.2.5 LpxTPa activity is modulated by Mg2+  	  
Lipid A modification with positively charged L-Ara4N and pEtN groups by the 
enzymes ArnT and EptA, respectively, improves bacterial survival in deleterious 
conditions such as limiting magnesium and exposure to cationic antimicrobial 
peptides(83)(1, 2). Modulation of LpxT activity permits pEtN modification at the 1-
phosphate group by EptA, without competition from LpxT (42, 74).  The P. aeruginosa 
L-Ara4N transferase can modify both phosphate groups of lipid A (34) and according to 
our findings the same can be said for LpxTPa.  Therefore, we speculated that LpxTPa 
activity might be inhibited under conditions that induce arnT transcription to prevent 
competition between phosphate group and L-Ara4N addition.  To test this possibility, 
lipid A was isolated from 32Pi-labelled P. aeruginosa cells grown in MOPS minimal 
medium supplemented with either 2 or 0.02 mM MgSO4 (high or low Mg2+), the latter of 
which has been previously shown to induce arnT transcription via PhoPQ and PmrAB 
(67, 68).  Growth in low Mg2+ resulted in absence of the tris-phosphorylated lipid A 
species and the appearance of L-Ara4N and palmitate-modified lipid A species due to 
ArnT and PagP activity, respectively (Fig. 2.8A, lane 3).  Absence of tris-phosphorylated 
lipid A was confirmed by MALDI-TOF MS (Fig. 2.8B).  Double L-Ara4N-modified 
species were also detected in our MS analysis of the wash fraction of this lipid A sample 
(Fig. 2.9).  These results suggest that limiting Mg2+ during growth results in inhibition of 
LpxTPa activity, either by influencing lpxTPa transcription or enzyme activity. 
  
 37 
 
Figure 2.8: LpxTPa activity is modulated by magnesium.    
 
A) E. coli was grown in LB, P. aeruginosa was grown in MOPS minimal medium 
supplemented with 2 or 0.02 mM MgSO4, as indicated.  When grown in low magnesium, 
lipid A tris-phosphate was not detected by TLC separation (lane 3).  Instead, L-Ara4N 
and palmitate-modified species were observed for both PA14 and PA14ΔlpxT grown in 
low magnesium (lanes 3 and 5).  B) MALDI-TOF MS analysis of the 480mM ammonium 
acetate lipid A eluate shows the absence of tris-phosphorylated species in PA14 grown in 
MOPS minimal medium supplemented with 0.02 mM MgSO4. Palmitoylation of the 
penta-acylated species (m/z at 1684.1) is indicated in green.  C) Relative gene expression 
of lpxTPa and arnT when grown in MOPS minimal medium supplemented with 0.02 mM 
MgSO4 compared to 2 mM MgSO4 shows that while lpxTPa transcription does not 
significantly change (<1.5-fold difference) with respect to magnesium concentration, 
arnT transcription significantly increases in 0.02 mM MgSO4. 
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Figure 2.9: Limiting magnesium induces arnT and pagP transcription, resulting in L-
Ara4N and palmitate modification.    
 
A) MALDI-TOF MS of the wash fraction of lipid A isolated from P. aeruginosa grown 
in MOPS minimal supplemented with 0.02 mM MgSO4 shows abundant L-Ara4N, 
double L-Ara4N (on either lipid A phosphate group), and palmitate-modified lipid A 
species.  B) Structures of lipid A species grown in limiting magnesium depicting L-
Ara4N and palmitate modifications 
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 It was then investigated whether Mg2+-dependent modulation of LpxTPa occurs at 
the transcriptional level.  Quantitative PCR was performed to compare the level of lpxTPa 
expression in high or low Mg2+, using the housekeeping gene clpX as an internal control 
(84).  The transcription of arnT was also analyzed under the same conditions as a positive 
control for Mg2+ regulation. While arnT transcription is strongly induced when Mg2+ is 
limiting, the transcription of lpxTPa does not significantly change (<1.5-fold difference) 
(Fig. 2.8C).  Mg2+-dependent modulation of LpxTPa activity is thus independent of lpxTPa 
transcription, as is the case in E. coli and S. enterica (42, 74).   
2.2.6  LpxTPa activity in low Mg2+ is partially restored in the PA14ΔarnT mutant 
 
 In E. coli and S. enterica, although LpxT-dependent lipid A phosphorylation at 
the 1-phosphate group occurs under normal laboratory growth conditions, its activity is 
inhibited when eptA transcription is activated by environmental stimuli (42, 74).  If lpxT 
is deleted, however, a small amount of pEtN-modified lipid A is detected even under 
conditions that do not normally induce eptA transcription (42).  Given that ArnT can add 
L-Ara4N to both phosphate groups of lipid A (Fig. 2.9) (34), we questioned whether a 
similar mechanism occurs in P. aeruginosa to control phosphate group and L-Ara4N 
addition thereby reducing their competition.  Since deletion of lpxTPa does not result in 
detectable L-Ara4N-modified lipid A when Mg2+ concentration is high (Fig. 2.3), we 
wondered if deletion of arnT would result in LpxTPa activity in low Mg2+.  Accordingly, 
32Pi-labelled lipid A was isolated from PA14ΔarnT grown in MOPS minimal medium 
 40 
supplemented with high or low Mg2+ and separated by TLC (Fig. 2.10).  When arnT is 
absent from the genome, the lipid A tris-phosphate species was partially restored in cells 
grown in low Mg2+  (Fig. 2.10A, lane 3).  Partial restoration of the tris-phosphorylated 
lipid A species in the PA14ΔarnT mutant grown in low Mg2+ was further confirmed by 
MALDI-TOF MS (Fig. 2.10C).  Together, these results suggest that coordinated control 
of lipid A modification at the phosphate groups occurs in P. aeruginosa. 
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Figure 2.10: LpxTPa activity in low magnesium is partially restored in the PA14ΔarnT 
mutant.     
 
A) E. coli was grown in LB, P. aeruginosa was grown in MOPS minimal medium 
supplemented with 2 or 0.02 mM MgSO4 as indicated.  When arnT is deleted, a small 
amount of tris-phosphorylated lipid A is detected in lipid A isolated from cells grown in 
low magnesium (lane 3).  B) When PA14ΔarnT is grown in MOPS minimal medium 
supplemented with 2 mM MgSO4, tris-phosphorylated lipid A species are readily 
detected in the 480mM ammonium acetate lipid A eluate fraction (m/z at 1525.8 and 
1695.9, respectively; red).  C) Tris-phosphorylated lipid A species isolated from 
PA14ΔarnT grown in MOPS minimal medium supplemented with 0.02 mM MgSO4 are 
detected as a minor species (m/z at 1526.1; red). 
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2.3 DISCUSSION 	  
 Modulation of the bacterial outer membrane is crucial for bacterial survival in a 
changing and potentially deleterious environment. When outer membrane integrity 
remains uncompromised (for example, when Mg2+ is plentiful), phosphate modification 
of lipid A occurs readily through the action of LpxT (30, 42).  However, when Mg2+ 
becomes scarce or cationic antimicrobial peptides are present, modification of lipid A 
with L-Ara4N, pEtN, or palmitate increase bacterial fitness (1, 2, 67, 68, 85).  
Environmental stimuli are sensed by two-component regulatory systems that orchestrate 
outer membrane remodelling by controlling the expression or activity of various lipid A 
modification enzymes in a coordinated manner (1, 2). For example, phosphorylation of 
lipid A must be inhibited, while simultaneously promoting the addition of cationic groups 
at the lipid A phosphates to increase membrane stability (42, 74). 
Previous studies have shown the presence of free pyrophosphate groups in P. 
aeruginosa lipid A samples analyzed by mass spectrometry, implicating that lipid A from 
this organism can be tris-phosphorylated (80).  We have now identified a P. aeruginosa 
LpxT ortholog that can function on both E. coli and P. aeruginosa lipid A (Figs. 2.2 and 
2.3).  As is the case in E. coli and S. enterica, phosphate group addition occurs under 
normal laboratory growth conditions in which Mg2+ concentration is replete (Figs. 2.1B 
and 2.4).  In all three organisms, limiting Mg2+ concentration inhibits LpxT activity while 
promoting expression of enzymes that add positively charged groups to lipid A.  
Importantly, there are several critical differences in LpxTPa activity from that of E. coli or 
S. enterica, which are highlighted in Table 2.1. These differences include the dual 
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positional specificity of LpxTPa for lipid A modification and competition with ArnT 
rather than EptA (Table 2.1). 
Table 2.1.  Summary of LpxT lipid A enzymatic characteristics  
Property of LpxT 
 
Microorganism 
 
E. coli/S. enterica  
 
P. aeruginosa 
 
 
Kinase activity at 
1-phosphate group? 
 
Yes, adds one  
phosphate group 
Yes, adds one or two phosphate 
groups 
 
Kinase activity at 
4'-phosphate group? 
 
No Yes, adds one phosphate group 
 
Conditions known to inhibit 
activity 
 
Low [Mg2+], mildly acidic pH, 
excess [Fe3+] Low [Mg
2+] 
 
Mg2+-dependent inhibition:  
transcriptional or post-
transcriptional? 
 
Post-transcriptional Post-transcriptional 
 
Regulatory system involved 
in LpxT inhibition 
 
PmrA-PmrB, via the small 
peptide PmrR 
Unknown, no PmrR ortholog 
present 
 
Competition with other lipid A 
modification enzymes? 
 
Yes, competes with EptA  
for modification at 1-phosphate 
group 
Yes, competes with ArnT  
for modification at both  
phosphate groups 
 
Other factors related to activity or 
expression 
 
Basal EptA activity when  
lpxT is deleted 
LpxTPa active in low [Mg2+] when 
arnT is deleted 
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Previous work in E. coli has demonstrated that LpxT is a member of the 
undecaprenyl-pyrophosphate (Und-PP) phosphatase family of enzymes, which remove a 
phosphate group from the carrier lipid Und-PP (30).  Und-P is a vital molecule required 
for shuttling polysaccharide intermediates involved in the synthesis of important 
polymers such as peptidoglycan and O-antigen across the inner membrane (30, 86). By 
removing a phosphate group from Und-PP, LpxT regenerates Und-P and thus plays a role 
in the cycle of bacterial cell envelope synthesis (86), while also modifying the lipid A 
anchor of LPS (30).  In E. coli, three additional Und-PP phosphatases (YbjG, PgpB, and 
UppP) are also present that can regenerate Und-P (86, 87).  UppP (formerly named 
BacA) is responsible for the majority of Und-PP dephosphorylation, while the other three 
account for the remaining activity (86).  Like LpxT, PgpB has activity on substrates other 
than Und-PP; it is one of three enzymes in E. coli that functions as a 
phosphatidylglycerolphosphate phosphatase (87–89).  These enzymes dephosphorylate 
phosphatidylglycerolphosphate, a necessary intermediate in the synthesis of the 
phospholipid phosphatidylglycerol (88). Although they have not yet been characterized, 
homologs of the other Und-PP phosphatases exist in P. aeruginosa as well.  
Characterization of LpxTPa positional specificity revealed that this enzyme has 
unique activity in that it can phosphorylate both the 1- and the 4' phosphate groups of 
lipid A (Figs. 2.6 and 2.9), while LpxT of E. coli modifies strictly the 1-position with a 
single phosphate group (82).  We have also demonstrated that deletion of lpxTPa results in 
loss of any lipid A tris-phosphate species, suggesting that LpxTPa is both necessary and 
responsible for phosphorylation of both positions of lipid A (Figs. 2.3A and B; 2.5).  
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Quite surprisingly, we observed that LpxTPa adds not only one phosphate group to the 1- 
or 4'-position of lipid A, but in some cases it can add two phosphate groups at the 1-
position, resulting in a minor lipid A 1-triphosphate species (Figs. 2.6 and 2.7).  This 
novel species has never been reported in any microorganism.  While it is unknown 
whether a specific regulatory condition exists that might promote such activity of LpxTPa, 
under the growth conditions used, this 1-triphosphate lipid A species is in very low 
abundance compared to 1- or 4'-diphosphate lipid A species.   
Another unexpected feature of the 1-triphosphate species is its lack of a 4' 
phosphate group linked to the glucosamine backbone.  While it is common for the lipid A 
1-phosphate group to cleave from the molecule during either the mild acid hydrolysis 
step of lipid A purification or in the mass spectrometer, the 4' phosphate group is not 
susceptible to such cleavage (25). 4'-dephosphorylated lipid A species are found in other 
organisms, such as Helicobacter pylori and Francisella tularensis, due to the activity of 
lipid A 4' phosphatases (50, 51).  Although a P. aeruginosa lipid A 4'-phosphatase has 
not been identified, P. aeruginosa has phosphatidylglycerolphosphate phosphatase 
orthologs.  As these phosphatases can remove a phosphate group from 
phosphatidylglycerolphosphate and leave behind a free hydroxyl group, it is possible that 
one of these proteins is responsible for removal of the 4' phosphate group (88).  We also 
cannot rule out the possibility that LpxTPa itself is acting as a lipid A 4' phosphatase.  The 
existence of this unusual lipid A species further demonstrates the need for a deeper 
understanding of lipid A modification systems in P. aeruginosa. 
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We have also found that LpxTPa activity is inhibited by growth in limiting Mg2+ 
independently of lpxTPa transcription.  While TLC and MALDI-TOF analysis of lipid A 
from bacteria grown in low Mg2+ demonstrated no phosphate group addition to lipid A 
(Fig. 2.8A and B), our quantitative PCR data revealed no significant change in lpxTPa 
transcription in response to limiting Mg2+ (Fig. 2.8C).  Instead, low Mg2+ induces 
transcription of arnT and pagP resulting in addition of L-Ara4N and palmitate, 
respectively (Fig. 2.8C and 2.9) (19, 67).  However, if arnT is deleted from the genome, 
LpxTPa remains partially active even when Mg2+ is limiting (Fig. 2.10). While tris-
phosphorylated lipid A species are present in the PA14ΔarnT mutant, this species is 
clearly diminished when cells are grown in low Mg2+ compared to growth in high Mg2+ 
(Fig. 2.10A and B).  This strongly suggests that the absence of tris-phosphorylated 
species in limiting Mg2+ is not merely due to competition from ArnT.  Instead, Mg2+-
dependent reduction of LpxTPa activity occurs independently from ArnT activity.  By 
altering the expression or activity of these two modification enzymes, P. aeruginosa has 
evolved a coordinated mechanism that mediates appropriate alterations in the outer 
membrane to promote survival in a changing environment.   
This report demonstrates another level of control involved in environmental 
adaptation that can contribute to P. aeruginosa’s ability to persist as a pathogen.   While 
LpxTPa-dependent lipid A phosphorylation has not yet been definitively linked to an 
increase in cell survival under a specific environmental condition, a new study has 
revealed that in a P. aeruginosa burned mouse acute infection model, an lpxTPa mutant 
was significantly less fit within the burn wound relative to analysis in succinate growth 
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medium (90).  Further investigation is necessary to determine the role of lpxTPa in acute 
P. aeruginosa infections. 
Although we have begun to characterize LpxTPa regulation, future work is 
required to determine which regulatory system or systems might be involved in Mg2+-
dependent modulation of LpxTPa activity.  Furthermore, we have not tested whether any 
other lipid A modification activation signals (i.e. cationic antimicrobial peptides) inhibit 
LpxTPa activity as well.  In P. aeruginosa both PhoPQ and PmrAB are independently 
activated by limiting Mg2+, while the latter system can also be activated by antimicrobial 
peptides such as polymyxin (67, 68).  In E. coli and S. enterica, inhibition of LpxT 
activity is PmrA-dependent.  Upon activation by inducing environmental conditions, 
PmrA acts as a transcription factor to regulate many target genes.  One such gene encodes 
the small regulatory protein PmrR, which interacts with LpxT to prevent its function (74).  
While PmrR orthologs exist in other enteric bacteria, including Citrobacter koseri and 
Klebsiella pneumonia, no such ortholog is present in microorganisms such as P. 
aeruginosa and N. meningitidis (74).  It is therefore likely that a distinct regulatory 
mechanism from E. coli and S. enterica is involved in LpxT regulation in other Gram-
negatives like P. aeruginosa.  Further investigation of regulatory mechanisms involved in 
modulation of LpxTPa activity and of P. aeruginosa lipid A remodelling in general is 
needed to better understand how this formidable pathogen adapts to its surroundings. 
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Chapter 3:  Extracellular zinc induces phosphoethanolamine addition to 
Pseudomonas aeruginosa lipid A via the ColRS two-component system2 
3.1    INTRODUCTION 
Modification of the canonical, hexa-acylated, bis-phosphorylated lipid A 
molecule produced in Gram-negatives (Fig. 1.2A; black) alter its chemical properties to 
bolster membrane integrity.  A repertoire of modification enzymes is responsible for the 
dynamic structure of P. aeruginosa lipid A.  Previous work from our laboratory recently 
revealed that P. aeruginosa has an LpxT lipid A kinase that adds an additional phosphate 
group to the 1- or the 4' position under standard laboratory growth conditions (Fig. 1.2A; 
brown)(31).  Hydroxylation of the secondary acyl chains can also occur by one of two 
LpxO enzymes, although the purpose for this modification remains to be elucidated (Fig. 
1.2B; orange) (91).  In addition to these modifications, the toxicity of P. aeruginosa lipid 
A can be affected by altering the acylation pattern due to activity of the PagL deacylase 
or the PagP palmitoyl-transferase (Fig. 1.2B; pink and green) (6, 19, 25, 34). Aside from 
influencing endotoxicity, lipid A modifications can contribute to antimicrobial peptide 
resistance (2).  Addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) to either phosphate 
group of P. aeruginosa lipid A by the enzyme ArnT is one such strategy (Fig. 1.2B; 
blue)(18, 33).  Palmitoylation has also been shown to increase antimicrobial resistance 
(19). 
                                                
2 Large portions of this chapter have been previously published (copyright by John Wiley and Sons, re-used 
with permission).  Nowicki EM, O’Brien JP, Brodbelt JS, Trent MS. 2015. Extracellular zinc induces 
phosphoethanolamine addition to Pseudomonas aeruginosa lipid A via the ColRS two-component system. 
Mol Microbiol. doi: 10.1111/mmi.13018.  (E.M.N. designed and performed experiments and wrote the 
manuscript under the supervision of M.S.T.; J.P.O. designed and performed the ESI and UVPD-MS 
experiments under the supervision of J.S.B.). 
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In Gram-negatives such as E. coli, Helicobacter pylori, Campylobacter jejuni, and 
Neisseria gonorrhoeae addition of phosphoethanolamine (pEtN) groups to lipid A by the 
enzyme EptA also promotes polymyxin resistance and virulence (42, 44–47, 51).  
Although P. aeruginosa has pEtN transferase orthologs, pEtN addition has not been 
observed in P. aeruginosa lipid A prepared from cells grown under conditions that induce 
this modification in other organisms or from P. aeruginosa clinical isolates.  We 
investigated whether or not P. aeruginosa lipid A could be modified with pEtN, and if so, 
under what conditions.  
Here we report that P. aeruginosa gene PA14_39020 is a functional pEtN 
transferase which we have named EptAPa that strictly modifes the 4' phosphate group of 
lipid A.  We also demonstrate that zinc acts as a signal to induce eptAPa transcription via 
the ColRS two-component system (Fig. 3.12).  While transcription of eptAPa is 
upregulated in response to Zn2+, arnT transcription is downregulated, suggesting that 
mechanisms are in place to mediate strict control over specific lipid A modifications.  
The existence of eptAPa reveals the potential for greater diversity in Pseudomonas lipid A 
structure and the versatility of the outer membrane. 
3.2    RESULTS 
3.2.1  P. aeruginosa has a functional EptA enzyme 
In silico analysis identified three P. aeruginosa eptA orthologs with significant 
identity to the S. enterica eptA (pmrC) ortholog (40).  These include PA14_58610 (24% 
identity, E-value 3e-28), PA14_21210 (43%, E-value 1e-149) and PA14_39020 (43%, E-
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value 6e-149).  Since pEtN-modified P. aeruginosa lipid A has not been previously 
reported, we tested whether these orthologs could function as a lipid A pEtN transferase 
by expressing each gene in trans in the E. coli eptA mutant (W3110ΔeptAEc).  32P-labeled 
lipid A was prepared and separated by TLC from these and relevant control strains 
including wild-type strain W3110 and W3110ΔeptAEc+empty vector.   
While no pEtN is detected in lipid A prepared from W3110 or W3110ΔeptAEc + 
empty vector (Fig. 3.1A, lanes 1 and 2), expression of both eptAEc and PA14_39020 
resulted in pEtN-modified lipid A (Fig. 3.1A, lanes 3 and 6). MALDI-TOF mass 
spectrometry (MS) analysis also confirmed that while W3110ΔeptAEc expressing empty 
vector had no pEtN (Fig. 3.1B), lipid A prepared from W3110ΔeptAEc+PA14_39020 
(peptAPa) was modified with pEtN, as evidenced by the ion of m/z 1920.4 (Fig. 3.1C; 
predicted [M-H]- at m/z 1920.2). 
 Since EptAPa can add pEtN to E. coli lipid A, we next determined whether EptAPa 
modified P. aeruginosa lipid A. 32P-labeled lipid A from wild-type strain PA14, 
PA14+empty vector or PA14+eptAPa was analyzed.  TLC separation of lipid A clearly 
demonstrated an altered profile of PA14 expressing peptAPa (Fig. 3.2A, lane 3) relative to 
PA14 or PA14+empty vector (Fig. 3.2A, lanes 1 and 2).  Penta-acylated, palmitoylated 
and L-Ara4N-modified lipid A species were observed by MALDI-TOF MS analysis of 
lipid A isolated from PA14+empty vector (Fig. 3.2B).  Whereas expression of eptAPa in 
PA14 resulted in abundant ions of m/z 1489.0 and 1727.3 which correspond to the pEtN-
modified lipid A species (Fig. 3.2C; predicted [M-H]- at m/z 1489.9 and 1728.1, 
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respectively).  These results reveal that P. aeruginosa has a functional lipid A pEtN-
transferase enzyme capable of modifying both E. coli and P. aeruginosa LPS.  
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Figure 3.1: Identification of a functional P. aeruginosa pEtN transferase (eptAPa) in E. 
coli.   
 
A)  P. aeruginosa eptA orthologs were heterologously expressed in K-12 E. coli strain 
W3110ΔeptA.  PA14_39020 and eptAEc were able to modify lipid A.  B) MALDI-TOF 
MS analysis of lipid A isolated from ΔeptA + empty vector shows no pEtN addition to 
lipid A, while (C) expression of PA14_39020 reveals pEtN modification.   
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Figure 3.2:  Heterologous expression of a P. aeruginosa eptA ortholog results in pEtN 
addition to the lipid A.   
 
A) Cells were grown in MOPS minimal medium.  Major 32P-labeled lipid A species are 
indicated with a cartoon corresponding to the lipid A structure; colors of modification 
groups are the same as those used in Fig. 1.  Expression of PA14_39020 (eptAPa) in P. 
aeruginosa results in modified lipid A species.  B) MALDI-TOF MS analysis of PA14 + 
empty vector grown in MOPS minimal medium reveals no pEtN addition to the 
molecule, while C) analysis of PA14 + peptAPa shows pEtN modification of the lipid A.  
The fractions most representative of pEtN modification are shown. 
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3.2.2  EptAPa adds pEtN strictly to the lipid A 4' phosphate group 
 
 Previous work from our laboratory has demonstrated that in P. aeruginosa, S. 
enterica and E. coli the position of lipid A modification can be important due to potential 
competition with other modification groups.  For example in S. enterica and E. coli EptA 
preferentially adds pEtN to the lipid A 1-phosphate group, which is the sole site of 
phosphorylation by the kinase LpxT (42).  Environmental conditions that activate eptA 
transcription simultaneously inhibit LpxT activity to prevent competition (42, 74).  
However, since both LpxT and ArnT enzymes in P. aeruginosa can act on either lipid A 
phosphate group (31, 33) we questioned whether EptAPa also has dual positional activity.  
To determine this we removed the 1- or the 4'-phosphate group of lipid A by 
heterologous expression of Fransicella novicida LpxE or LpxF phosphatases (49, 50), 
respectively, and tested the ability of EptAPa to modify lipid A.  This experiment was 
done in E. coli strain BN2 (4) since its lipid A is penta-acylated, and LpxF can only act 
on penta-acylated lipid A (50).  BN2 also lacks some lipid A modification machinery 
including LpxT to facilitate easier analysis of the lipid A profiles.  
Expression of eptAPa resulted in a pEtN-modified lipid A species that migrated 
below the unmodified bis-phosphorylated species (Fig. Fig. 3.3A, lane 2).  Expression of 
either lpxE or lpxF caused a marked increase of mono-phosphorylated lipid A, which 
migrates near the top of the TLC plate (Fig. 3.3A, lanes 3 and 5).  Simultaneous 
expression of eptAPa and lpxE resulted in the appearance of a species that migrated a 
distance between that of unmodified bis-phosphorylated lipid A and pEtN-modified lipid  
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Figure 3.3:  EptAPa adds pEtN exclusively to the lipid A 4' phosphate group.   
 
A) Cells were grown in LB broth. Major 32P-labeled lipid A species are indicated with a 
cartoon corresponding to the lipid A structure; colors of modification groups are the same 
as those used in Fig. 1.  Heterologous expression of eptAPa in BN2 results in a pEtN-
modified species, while expression of either the lpxEFn or lpxFFn phosphatase results in an 
increased of monophosphorylated species.  Co-expression of lpxEFn and eptAPa results in 
pEtN addition to the 1-dephosphorylated lipid A molecule, while no pEtN addition of 4' –
dephosphorylated species is detected. B)  MALDI-TOF analysis of lipid A isolated from 
BN2 coexpressing lpxEFn and eptAPa corroborates the presence of a monophosphorylated, 
pEtN-modified species.  C) MALDI-TOF analysis of lipid A isolated from BN2 
coexpressing lpxFFn and eptAPa reveals that when the 4’ phosphate group is removed, 
pEtN addition does not occur. 
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A (Fig. 3.3A, lane 4).  MALDI-TOF MS confirmed this species to be pEtN-modified 
mono-phosphorylated lipid A (Fig. 3.3B).  This same pEtN-modified species was not 
detected when LpxF was expressed with eptAPa (Fig 3.3A, lane 6).  The lack of pEtN 
addition to 4'-dephosphorylated lipid A was further confirmed by MALDI-TOF MS as 
simultaneous expression of EptAPa and LpxF resulted in only a single ion of m/z 1506.1, 
corresponding to mono-phosphorylated lipid A (Fig. 3.3C; predicted [M-H]- at m/z 
1507.1).   
EptAPa-dependent addition of pEtN to the 4' phosphate group of BN2 and PA14 
lipid A was corroborated by ultraviolet photodissociation (UVPD) tandem MS (Figs. 3.4, 
3.5 and 3.6).  For all UVPD mass spectra, cleavage sites 7 and 8 provided evidence of the 
presence of a pEtN group.  In addition, the glycosidic and cross-ring cleavages at 
cleavage sites 10 and 11 in the fragmentation map shown in Figure 3.4, sites 9-12 in 
Figure 3.5, and sites 9-12 and 17-21 in Figure 3.6 further support the location of the pEtN 
modification at the 4′ phosphate group of each lipid A species.  Taken together, these 
results demonstrate that EptAPa functions strictly at the 4′ phosphate group, unlike any 
previously characterized EptA enzyme. 
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Figure 3.4: UVPD mass spectrum and fragmentation map of doubly deprotonated lipid 
A prepared from BN2 + peptAPa [Mr = 1710.03].  
 
Key fragments and cleavage sites that support the identification and location of the 4′ 
modification are shown in red font.  The precursor ion is marked with an asterisk.   
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Figure 3.5:  UVPD mass spectrum and fragmentation map of doubly deprotonated lipid 
A prepared from BN2 + peptAPa + plpxE [Mr = 1630.06].  
 
Key fragments and cleavage sites that support the identification and location of the 4′ 
modification are shown in red font.  The precursor ion is marked with an asterisk.  
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Figure 3.6:  UVPD mass spectrum and fragmentation map of singly deprotonated lipid 
A prepared from PA14 + peptAPa [Mr = 1489.91]. 
 
Key fragments and cleavage sites that support the identification and location of the 4′ 
modification are shown in red font.  The precursor ion is marked with an asterisk. 
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3.2.3  Extracellular zinc induces pEtN addition to lipid A 
 
 In S. enterica, modification of lipid A with pEtN is induced via the PmrAB two-
component system in response to mildly acidic pH (57), and indirectly via the PhoPQ 
system when Mg2+ is limiting or cationic antimicrobial peptides are present (62, 92).  
Since none of these signals induced pEtN addition to P. aeruginosa lipid A (data not 
shown), we next tested transition metals including Fe3+ and Zn2+, which activate PmrAB 
in E. coli (59, 61).  We also tested Ga3+ due to its chemical similarity to Fe3+, and Cd2+, 
which is closely related to Zn2+ (93, 94).   Transition metals Co2+, Cu2+, Mn2+, and Ni2+ 
were also tested for their ability to induce pEtN modification of lipid A since they are 
associated with biological catalysts and are commonly found in the environment (95, 96).   
Lipid A was isolated from 32P-labeled P. aeruginosa grown in LB alone or 
supplemented with metal.  Addition of extracellular Zn2+ but no other metal tested 
resulted in modified lipid A (Fig. 3.7A, lane 3).  Zn2+-dependent modification was 
abolished when eptAPa was deleted from the genome and restored upon complementation 
with the native eptAPa promoter (Figs. 3.7A, lanes 4 and 5), suggesting that the changes 
observed were due to EptAPa activity.  To determine whether Zn2+ induced transcription 
of eptAPa, cDNA was prepared from cells grown in the presence or absence of Zn2+.  As 
shown by both quantitative and semi-quantitative reverse-transcriptase (RT) PCR, eptAPa 
gene expression is induced when Zn2+ is added to the growth media (Figs. 3.7B and 3.8).   
These results indicate that transcription of eptAPa is dependent on extracellular Zn2+. 
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Figure 3.7:  Zn2+ induces transcription of eptAPa. 
A) Cells were grown in LB broth. Major 32P-labeled lipid A species are indicated with a 
cartoon corresponding to the lipid A structure; colors of modification groups are the same 
as those used in Fig. 1. Both heterologous expression of eptAPa as well as addition of 
2mM ZnSO4 to the media results in pEtN addition to lipid A.  This modification is not 
detectable in the eptAPa mutant, but restored upon complementation with peptAnprom. B) 
Relative gene expression of eptAPa and arnT in response to Zn2+. Transcription of eptAPa 
is induced by 2mM ZnSO4 approximately 21-fold. Zn2+ downregulates arnT transcription 
by >4-fold. Ratios were standardized relative to expression of the housekeeping control 
gene, clpX. C), D) and E).  MALDI-TOF MS analysis of lipid A prepared from cells 
grown in LB broth. C) Analysis of PA14 + 2mM ZnSO4 reveals pEtN addition to lipid A, 
while D)  ΔeptAPa + 2mM ZnSO4 shows no pEtN modification, but instead L-Ara4N 
addition.  E) Complementation of ΔeptAPa with peptAnprom restores pEtN addition to the 
lipid A in response to Zn2+.  The fractions most representative of pEtN modification are 
shown. 
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Figure 3.8: Excess zinc induces transcription of eptAPa. 
 
Semi-quantitative RT-PCR shows no detectable eptAPa transcription in PA14 cells grown 
in LB alone, while addition of 1mM ZnSO4 results in detectable transcription.  No 
transcription of eptAPa is visualized in PA14ΔcolR grown in LB with 1mM ZnSO4.  
When this mutant is complemented, eptAPa transcription in response to 1mM ZnSO4 can 
once again be seen. The stably expressed housekeeping gene clpX was used as a control. 
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To confirm whether Zn2+-dependent induction of EptAPa synthesis resulted in 
pEtN addition to P. aeruginosa lipid A, MALDI-TOF MS analysis of lipid A isolated 
from cells grown with or without Zn2+ was performed.  Wild-type P. aeruginosa lipid A 
was modified with pEtN in the presence of Zn2+ (Fig. 3.7C), while lipid A prepared from 
the PA14ΔeptAPa mutant showed no pEtN modification when Zn2+ was added to the 
media (Fig. 3.7D).  Complementation of PA14ΔeptAPa using the native eptAPa promoter 
restored Zn2+-dependent pEtN addition to the lipid A (Figs. 3.7E).  MS analysis revealed 
that in addition to pEtN addition, L-Ara4N-modified lipid A was present in PA14 grown 
with Zn2+ (Fig. 3.7C). We were therefore curious as to how Zn2+ might influence L-
Ara4N addition to lipid A.  Since Zn2+ affected the transcription of eptAPa, we assessed 
whether Zn2+ altered arnT gene expression by performing quantitative RT-PCR.  While 
eptAPa transcription increased by 21-fold in the presence of 2mM Zn2+, arnT transcription 
was downregulated >4-fold (Fig. 3.7B).  This result indicates that pEtN modification is 
selected for in the presence of Zn2+ while arnT expression, and thus L-Ara4N 
modification of lipid A, is downregulated. 
 
3.2.4  The ColRS two-component system induces pEtN addition to lipid A  
 
 Since inducible lipid A modification genes like eptA are commonly regulated by two-
component systems, our next goal was to determine the system responsible for eptAPa 
transcriptional activation in response to Zn2+.  The ColRS system has recently been 
shown to respond to transition metals including Zn2+ (72). Our first approach was 
therefore to investigate the presence of potential ColR binding sites in the eptAPa 
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promoter. A consensus ColR binding site has been determined for promoters of genes 
within the ColR regulon in P. putida (97).  Using the Virtual Footprint online analysis 
tool (98), we found three potential ColR binding sites within the eptAPa promoter region 
with close agreement to this consensus sequence (Fig. 3.9A), suggesting that ColR binds 
to the eptAPa promoter.  It was then tested whether overexpression of colR could induce 
eptAPa transcription by semi-quantitative RT-PCR of cDNA.  Response regulators pmrA 
and phoP, which directly or indirectly regulate eptA transcription in S. enterica were also 
tested.  Only overexpression of colR resulted in detectable transcription of eptAPa (Fig. 
3.9B).  Lipid A was modified with pEtN upon overexpression of colR, as demonstrated 
by both TLC separation of 32P-labeled lipid A (Fig. 3.9C, lane 4) and MALDI-TOF MS 
analysis of PA14 + pcolR (Fig. 3.9D).	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Figure 3.9: The two-component system response regulator ColR activates eptAPa 
transcription.   
 
A) Putative eptAPa promoter ColR binding sites are in bold and boxed; nucleotides that 
deviate from the conserved recognition sequence in P. putida 
((T/C)(T/C)NA(C/G)NN(T/C)TTTTT(C/G)AC) are indicated in red.  The number of base 
pairs between ColR sites or upstream of the start codon is indicated. B) Semi-quantitative 
RT-PCR of cDNA prepared from cells grown in MOPS minimal medium.  While eptAPa 
is not transcribed in PA14, expression of colR in trans results in eptAPa transcription.  C) 
Lipid A was isolated from 32P-labeled cells grown in MOPS minimal medium and 
separated by TLC.  Only expression of the colR response regulator, and not pmrA or 
phoP, results in pEtN modification of lipid A.   D) MALDI-TOF MS analysis of PA14 + 
pcolR grown in MOPS minimal medium reveals pEtN-modified lipid A.  The fraction 
most representative of pEtN modification is shown. 
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 To determine whether ColR induction of eptAPa transcription is dependent on 
Zn2+, a PA14 colR deletion mutant was generated and assessed for transcription of eptAPa 
in the presence or absence of Zn2+ by both quantitative and semi-quantitative RT-PCR 
analysis.  Although a Zn2+ concentration of 2mM had been used in the initial Zn2+ assay 
experiments, the PA14ΔcolR mutant was sensitive to 2mM Zn2+.  Instead, 1mM Zn2+ was 
used, which was sufficient to visualize pEtN modification in PA14 (Fig. 3.10A, lane 2).  
Minimal eptAPa transcription was detected in response to Zn2+ upon deletion of colR; 
complementation of this mutant restored Zn2+-dependent eptAPa transcription by >4-fold 
(Fig. 3.10B, Fig. 3.8).  While 1mM Zn2+ induced pEtN modification of PA14 lipid A 
(Fig. 3.10A, lane 2), lipid A from the PA14ΔcolR was not modified with pEtN in 
response to Zn2+, as determined by both TLC separation of 32P-labeled lipid A and 
MALDI-TOF MS analysis (Fig. 3.10A, lane 3 and Fig. 3.10C).  pEtN addition was 
restored upon complementation of the colR mutant with pcolRnprom (Fig. 3.10A, lane 4 
and Fig. 3.10D).  A PA14 colS mutant and complemented mutant were also tested for 
pEtN addition to lipid A in response to Zn2+ by TLC separation of 32P-labeled lipid A. As 
for the colR mutant, lipid A modification with pEtN was not detected in the colS mutant 
grown in the presence of 1mM Zn2+, but was restored upon complementation of colS with 
pcolSnprom (Fig. 3.11, lanes 3 and 4). These results demonstrate that the ColRS system 
induces pEtN addition to lipid A upon sensing Zn2+.   
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Figure 3.10: Deletion of colR results in loss of Zn2+-induced pEtN modification of P. 
aeruginosa lipid A.    
 
A) Lipid A was isolated from 32P-labeled cells grown in LB broth and separated by TLC.  
While pEtN modification of lipid A is detectable for PA14 + 1mM ZnSO4, no such 
modification occurs in PA14ΔcolR in response to Zn2+.  Modification is restored in the 
complemented mutant. B) Relative gene expression of eptAPa and arnT in response to 
Zn2+ in the ΔcolR mutant or complemented mutant. Transcription of eptAPa in the 
presence of 1mM ZnSO4 is induced >4-fold in a ColR-dependent manner.  An 
approximately 10-fold decrease in arnT transcription in the presence of 1mM ZnSO4 is 
also dependent on ColR. Ratios were standardized relative to expression of the 
housekeeping control gene, clpX. C) and D). MALDI-TOF MS analysis of lipid A 
prepared from cells grown in LB broth.  C) No pEtN modification is detected in the 
PA14ΔcolR mutant grown in LB + 1mM ZnSO4.  D) Complementation of PA14ΔcolR 
with pcolRnprom restores the Zn2+-dependent pEtN addition to the lipid A.  The fractions 
most representative of pEtN modification are shown. 
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We also investigated whether the downregulation of arnT transcription in the 
presence of Zn2+ was dependent on the ColR response regulator.  Gene expression of 
arnT was analyzed by quantitative RT-PCR in the PA14 colR mutant and complemented 
strains in the presence of 1mM Zn2+.  Transcription of arnT was reduced by 
approximately 10-fold upon complementation of colR (Fig. 3.10B).  This result indicates 
that ColR activates transcription of eptAPa in response to Zn2+ while downregulating arnT 
transcription. 
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Figure 3.11:  Deletion of colS results in loss of Zn2+-induced pEtN modification of P. 
aeruginosa lipid A.   
 
Lipid A was isolated from 32P-labeled cells grown in LB broth and separated by TLC.  
Lipid A species modified with pEtN were observed in PA14 supplemented with 1mM 
ZnSO4 (lane 2).  Deletion of colS resulted in no pEtN modification of lipid A in response 
to Zn2+ (lane 3).  Modification is restored in the mutant complemented with colS (lane 4). 
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3.3    DISCUSSION 
Changes in the environment require bacterial outer membrane remodeling, 
including LPS structural changes, to promote membrane stability (1).  L-Ara4N addition 
to lipid A phosphate groups contributes to cationic antimicrobial peptide resistance in P. 
aeruginosa, E. coli and S. enterica (18, 40, 42).  The addition of the amine-containing 
residue pEtN can also result in increased peptide resistance (42, 44), and in some 
organisms is a crucial factor for host infection (45, 47).  Lipid A modifications in P. 
aeruginosa have been well-studied, yet despite the existence of eptA orthologs, pEtN 
addition has never been observed.  Due to the importance of pEtN lipid A modification in 
other organisms, we investigated the functionality and regulation of P. aeruginosa eptA 
orthologs.  In this report, we identify and characterize a functional P. aeruginosa lipid A 
pEtN transferase and determine that Zn2+ induces transcription of eptAPa via the 
Pseudomonas-specific ColRS system (Fig. 3.12).  
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Figure 3.12:  Proposed model of pEtN addition to P. aeruginosa lipid A.   
 
Upon sensing excess Zn2+, the ColS sensor kinase (green) autophosphorylates and 
transfers a phosphate group to the response regulator ColR (green).  ColR then acts as a 
transcription factor, inducing transcription of eptAPa (red) while inhibiting that of arnT 
(blue).  EptAPa protein is synthesized and transfers pEtN to the 4ʹ′ phosphate group of 
lipid A in the inner membrane.  Lipid A is then transported to the bacterial cell surface.  
Following transport to the outer membrane, the 3-hydroxydecanoate acyl chain is 
removed by PagL (not shown).  Cellular components are labelled as follows:  OM, outer 
membrane; P, periplasm; IM, inner membrane; C, cytoplasm).  
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Overexpression of three P. aeruginosa eptA orthologs in E. coli revealed that 
PA14_39020 (eptAPa) was able to modify lipid A with pEtN (Fig. 3.1A and C).  It is 
likely that the other two orthologs add pEtN to other targets in the cell.  Based on its 
homology to S. enterica CptA, PA14_58610 may be the enzyme responsible for adding 
pEtN to the core of P. aeruginosa LPS (43, 99). While a very minor amount of lipid A 
modification is detected by TLC separation of lipid A upon expression of PA14_21210 in 
PA14, lipid A is probably not the primary target of this enzyme.  It is possible that this 
enzyme modifies an as yet unidentified target, as pEtN transferase enzymes in other 
organisms have been shown to modify structural proteins of the flagellum and pilus (46, 
100), and in doing so has some very minor, non-specific activity toward lipid A.  This 
activity toward lipid A, however, is so minor that is cannot be detected by mass 
spectrometry analysis (data not shown).   
We characterized the site-specificity of pEtN addition to lipid A due to the 
potential for competition with other modification groups.  Whereas pEtN addition occurs 
specifically or preferentially at the 1-phosphate group of lipid A in H. pylori (101) and S. 
enterica (42), respectively, analysis of EptAPa activity in E. coli revealed that this enzyme 
acts solely at the 4' position (Figs. 3.3, 3.4 and 3.5).  EptAPa activity thus differs from 
ArnT and LpxT enzymes in P. aeruginosa that can modify either lipid A phosphate group 
(31, 33).  
Investigation of conditions that induce pEtN modification revealed that excess 
Zn2+ acts as the activating signal for eptAPa transcription (Fig. 4.7A, B, and C).  
Pseudomonas species are readily found in the soil and aqueous environments which can 
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be contaminated with metals due to waste runoff from mines, smelting, and other 
industrial facilities (95, 102, 103).  In such environments, Pseudomonas can be exposed 
to high levels of metal pollutants and has thus evolved the ability to alter gene expression 
to promote metal tolerance (12, 71, 104, 105).  Excess Zn2+ may also be relevant in 
healthcare settings as concentrations up to 1mM can leach out from latex catheters and 
gloves (104, 106).  Deletion of eptAPa, however, does not result in increased sensitivity to 
Zn2+ or to Cd2+, Ga3+, Fe3+, Co2+, Cu2+, Mn2+ or Ni2+.  Under laboratory settings Zn2+-
induced pEtN addition to lipid A has no effect on polymyxin resistance, biocide 
tolerance, or biofilm formation (data not shown).  As the ColRS system was previously 
implicated to play a role in polymyxin resistance, unidentified genes other than eptAPa 
within the ColRS regulon are likely involved in this resistance.  The fact that P. 
aeruginosa has evolved regulatory mechanisms to control pEtN addition to lipid A, 
however, suggests the importance of this modification for conditions we have not yet 
identified. 
Extracellular metals are sensed by one of three two-component systems in 
Pseudomonas species: CzcRS (104), CopRS (12) and ColRS (71, 72).  Both CzcRS 
(activated by Zn2+) and CopRS (activated by Cu2+) induce expression of the heavy metal 
efflux pump CzcCBA while downregulating the OprD porin, leading to decreased 
carbapenem and imipenem uptake (12, 104).  In P. putida, the ColRS system senses Zn2+, 
Fe3+, Mn2+ and Cd2+, and mutants of colR and colS display lower tolerance to these 
metals (72).  We have now determined Zn2+ to be an activating signal for ColRS in P. 
aeruginosa (Fig. 3.10 and 3.11).  Additionally, the PA14 colR and colS mutants are more 
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sensitive to Zn2+ than wild-type, suggesting a role for the ColRS system in Zn2+ tolerance 
in P. aeruginosa.  While the ColRS system is important for metal tolerance in P. putida 
and deletion of multiple genes in the ColRS regulon results in increased metal sensitivity, 
no individual ColRS-regulated gene has a major contribution to metal tolerance (72).  It 
is likely that multiple genes in the P. aeruginosa ColRS regulon are involved in Zn2+ 
tolerance, which could explain why the eptAPa isogenic mutant does not have any growth 
defect in media with Zn2+. 
Our demonstration of pEtN-modified lipid A via the ColRS system in response to 
Zn2+  (Fig. 3.12) reveals that lipid A remodeling in P. aeruginosa is more complex than 
previously realized.  Extracellular Zn2+ specifically induces transcription of eptAPa and 
not arnT through the ColR response regulator, demonstrating coordinated control over 
lipid A modifications. In addition to selectively inducing expression of eptAPa Zn2+ 
downregulates arnT transcription by over 4-fold (Fig. 3.7B). This is interesting given that 
ArnT-mediated L-Ara4N modification typically plays a more significant role in virulence 
and antimicrobial peptide resistance than eptA in organisms possessing both modification 
enzymes (42, 43).  While eptAPa does not seem to be involved in metal or polymyxin 
resistance, there is likely an evolutionary reason for this targeted induction of eptAPa 
transcription.  Our findings demonstrate the tight control of P. aeruginosa lipid A 
modification systems, and suggest the need for further studies to better elucidate the 
mechanisms involved in outer membrane remodeling and its contribution to bacterial 
persistence and versatility. 
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Chapter 4:  Conclusions and Future Directions 
4.1     THE IMPORTANCE OF CONTINUED STUDY OF P. AERUGINOSA LIPID A 
MODIFICATIONS 
4.1.1  Further characterization of P. aeruginosa lipid A remodeling systems 
The underlying mechanisms responsible for P. aeruginosa virulence are 
continuously being examined in an attempt to improve treatment of Pseudomonas 
infections and improve patient prognosis.  While P. aeruginosa outer membrane 
remodeling is just one of many factors that contribute to this organism’s survival and 
pathogenesis, the interplay between lipid A and the host innate immune system make it a 
particularly important molecule to study.  Our finding and characterization of functional 
LpxT and EptA enzymes as well as their ability to be regulated in response to specific 
environmental cues demonstrates the strict control of LPS remodeling in P. aeruginosa.   
As discussed in Chapter 2, there is much we still do not understand about the 
biological role of the LpxT enzyme.  Although additional studies are necessary, several 
ideas have been proposed regarding the purpose of LpxT including the potential to use a 
diphosphate group on lipid A as an energy source (30).  Further, as LpxT uses as its 
substrate a carrier lipid involved in both peptidoglycan synthesis and LPS O-antigen 
translocation, it is possible that LpxT-dependent modification of lipid A helps to couple 
peptidoglycan and LPS biosynthesis (30, 86). The precise mechanism involved in 
regulation of LpxT activity in P. aeruginosa is also currently unknown.  While no PmrR 
ortholog is present in the P. aeruignosa genome, it is possible that either the PhoPQ or 
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PmrAB system, which both respond to limiting Mg2+, are involved in regulating LpxT 
activity (31).   
In addition to LpxT, the significance of EptA and LpxO enzymes in P. 
aeruginosa remains unclear.  Although pEtN addition to lipid A in organisms such as H. 
pylori and N. gonorrhoeae plays a critical role in CAMP resistance and virulence within 
a host (44, 47), the biological function of this modification in P. aeruginosa is yet to be 
elucidated.  The role of hydroxylation of the lipid A secondary acyl chains by the LpxO 
enzymes in P. aeruginosa is also unknown.  As an ortholog of VisP exists in P. 
aeruginosa, it is possible that VisP and the LpxO proteins interact and are involved in 
some sort of stress response, similar to the case in S. enterica (29).  Future studies are 
necessary to determine whether these proteins interact and if so, what role they may play. 
4.1.2  The role of P. aeruginosa lipid A remodeling systems in polymyxin resistance 
One of the most critical aspects of P. aeruginosa pathogenesis that remains to be 
fully understood is the precise role of lipid A remodeling in polymyxin resistance.  
Polymyxin B and its closely related derivative, polymyxin E (or colistin) are cyclic 
CAMPS produced by Gram-positive Bacillus species (32).  They are also commonly the 
drugs of last resort used to treat multi-drug resistant P. aeruginosa infections (54, 107).  
These cationic peptides bind to the phosphate groups of lipid A to enable penetration of 
the outer membrane and cell lysis (108).  Lipid A remodeling is a critical factor leading 
to resistance. High levels of polymyxin and colistin resistance among CF clinical isolates 
is common, and leads to increased lung damage and worsened prognosis in patients 
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harboring such strains (107).  Although modification of lipid A with L-Ara4N in 
organisms like E. coli and S. enterica plays a significant role in CAMP resistance (38, 39, 
42), in P. aeruginosa the exact contribution of this modification is still not fully 
understood.  Ernst and colleagues have reported that addition of L-Ara4N to P. 
aeruginosa lipid A alone does not explain the amount of resistance seen among highly 
resistant clinical isolates (53).  Yet despite this, L-Ara4N modification is a characteristic 
of virtually all colistin-resistant clinical isolates.  Further, deletion of L-Ara4N from the 
genome of polymyxin-resistant clinical isolates results in a significant decrease in 
resistance (109).  It is thought that L-Ara4N can predispose P. aeruginosa to resist low 
levels of CAMPS and promote further resistance (53).  The pharmacokinetics of these 
cationic peptides are extremely complex and still not well understood, and it is likely that 
subinhibitory CAMP concentrations could “prime” bacteria to induce other more robust 
mechanisms of resistance (53, 107).   
Efforts have been made to better understand the regulatory systems that control 
lipid A remodeling and consequently polymyxin resistance in P. aeruginosa.  A subset of 
CF patients treated with colistin are found to have extremely high (>512 mg/L) levels of 
colistin resistance, which is commonly associated with mutation or deletion of phoQ 
(109).  A recent study sought to identify genes critical for the high levels of resistance 
seen in these P. aeruginosa phoQ mutants (54, 109). The CprRS and ColRS two-
component systems were found to contribute significantly to polymyxin resistance in 
phoQ mutants; deleting cprRS or colRS resulted in an approximately 4-fold decrease in 
polymyxin resistance relative to the phoQ mutant (54).  Perhaps most interestingly, 
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however, is that despite the increased polymyxin sensitivity in the ΔphoQΔcolRS and 
ΔphoQΔcprRS mutants, they retain L-4AraN lipid A modification (54). This suggests that 
there are additional factors or mechanisms aside from L-4AraN responsible for 
polymyxin resistance, and that these factors are likely regulated by the ColRS and CprRS 
two component systems.  The CprRS system has recently been identified and 
characterized in P. aeruginosa (69).  Despite extensive characterization of the ColRS 
system in P. putida (97) and our recent investigation of its role in inducing eptAPa gene 
expression, the precise role of this system in P. aeruginosa remains unknown.  Further 
characterization of transcriptional targets of both systems and the biological functions of 
these genes is warranted to expand our understanding of P. aeruginosa CAMP resistance. 
 
4.2 UNDERSTANDING THE ROLE OF LIPID A IN P. AERUGINOSA INFECTIONS 
 
4.2.1  Characterization of the lipid A profile in chronological P. aeruginosa isolates 
from CF patients 
 
It is important to apply the knowledge gained from studying P. aeruginosa lipid A 
modifications in laboratory strains to clinically relevant situations.  Due to P. 
aeruginosa’s prevalence in chronic CF infections, the lung environment and its effect on 
growth and virulence must be considered. As described in Chapter 1, previous studies 
have demonstrated that there are CF-specific forms of lipid A, with constitutive 
modifications and physiological consequences (15, 34, 53).  Changes in these CF-specific 
lipid A modifications do occur, however, depending on the stage or severity of CF 
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infection (25, 53).  To date, these studies have only compared lipid A species from 
patients of different ages or with different types of infection, not from within the same 
patient.  To better understand if these modifications are adaptations that occur over time 
within the same patient as opposed to host differences, studies should be done comparing 
lipid A species from chronic infection isolates of the same patient.  
4.2.2  Characterization of lipid A changes within P. aeruginosa biofilms 
 
Another question of interest is whether cells growing within surface-associated cell 
communities, or biofilms, express different forms of lipid A throughout.  To this end, 
Haagensen and colleagues have shown that the distribution of polymyxin-tolerant P. 
aeruginosa cells varies within a biofilm, with only the cap-forming subpopulation of cells 
expressing the protective arn (pmrK) operon (110).  This study tested this question by 
growing ‘typical’ surface-attached biofilms in citrate media.  Carbon source can vary 
tremendously depending on the surrounding environment and can affect biofilm shape 
(110); it will therefore be important to further investigate the distribution of various lipid 
A subtypes within P. aeruginosa biofilms grown in various environmental conditions and 
with different carbon sources.   
Addressing the distribution of lipid A modifications within biofilms will also need to 
be approached differently when looking at CF infection isolates.  In the early stages of 
CF infection, P. aeruginosa grows as individual freely-swimming cells within the lung’s 
surface fluid.  During later stages of infection, however, the bacteria often switch to a 
biofilm mode of growth, forming rounded cell-to-cell attached groups known as 
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microcolonies (111–114).  This change in growth is also associated with rapid 
deterioration of the lung (111).  As biofilm-grown P. aeruginosa has been shown to 
express more inflammatory LPS than planktonically grown cells (115), it would be of 
interest to understand how the formation of microcolonies contributes to lipid A 
modification of P. aeruginosa in CF infections.  Since microcolonies within the CF lung 
fundamentally differ from biofilms in that they are not attached to a surface, the effect of 
a more relevant growth media on P. aeruginosa lipid A structure remains to be examined 
(113, 116).  Ideally, CF isolates should be cultured in CF sputum.  Another option is to 
work with a medium that compositionally resembles sputum.  To this end, synthetic 
cystic fibrosis medium (SCFM) has been developed, and has been shown to more closely 
mimic growth conditions found in the lung (117, 118).  Future studies should begin to 
address the distribution of lipid A modifications in P. aeruginosa microcolonies formed 
in SCFM and/or CF sputum. 
4.2.3  The role of lipid A modifications in vivo:  the need for improved animal 
models 
 
Perhaps the most important step toward better understanding the biological role of 
lipid A and the effects of various lipid A modifications will be the development of 
improved animal models for more accurate in vivo studies.  For a number of years, there 
was a lack of an ideal animal model for the study of P. aeruginosa CF infection in vivo.  
While a number of models exist in which the animal exhibited some symptoms of CF, 
none of these models resulted in long-term, chronic bacterial infection as well as 
associated symptoms of the disease (111).  One example is the CFTR-deficient mouse 
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model developed in 1992 (119, 120).  While these mice did show elevated 
proinflammatory signaling, they did not spontaneously develop CF lung disease and also 
were able to clear even large doses of typical CF-associated pathogens without antibiotic 
treatment (121).  Recently, CFTR-deficient and CFTR mutant pigs have been made (122, 
123), and shown to spontaneously develop lung disease characteristic of CF (124).  This 
promising new model will potentially be useful for testing the pharmacological efficacy 
of new drugs to treat CF infections (121). 
Another critical flaw of animal models is the differential lipid A stimulation of TLR-
4 in humans versus animal hosts.  As discussed in Chapter 1, the shape and acylation 
pattern of lipid A affect its immunostimulatory properties, with hexa-acylated structures 
characteristic of E. coli and P. aeruginosa CF isolates showing the greatest levels of 
TLR-4 stimulation (125).  Additionally, differences also exist in TLR-4 between species 
or even individuals within the same species that affect the biological response a given 
lipid A molecule will elicit (126).  Although human TLR-4 robustly responds to hexa-
acylated lipid A structures, it is not stimulated by penta-acylated species (126, 127).  In 
contrast mouse TLR-4 responds strongly to both penta and hexa-acylated species, and 
thus does not respond to changes in the lipid A acylation pattern that might occur in vivo 
(126, 128).  It is possible that this contributed to the failure of the mouse CF model to 
accurately simulate the pulmonary damage seen in human infection (121). 
Using various P. aeruginosa isolates as TLR-4 agonists, an 82-amino acid 
hypervariable region in mouse TLR-4 was found to recognize both the hexa-acylated 
lipid A found in Pseudomonas chronic infection isolates and the penta-acylated form 
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found in acute infection and environmental isolates .  Despite the clear difference in lipid 
A recognition between human and mouse TLR4, mouse studies attempting to look at the 
in vivo effects of various lipid A modifications have continued to be the norm.  Hajjar 
and colleagues have now developed a transgenic humanized TLR4/MD2 line for more 
accurate in vivo studies of bacterial endotoxin (129).  With this humanized mouse model, 
the molecular mechanisms related to pathogenesis within mammalian hosts can now be 
better understood. 
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Chapter 5:  Materials and Methods 
5.1      METHODS 
5.1.1  Bacterial strains and growth conditions 
Bacterial strains and plasmids used in Chapter 2 are listed in Table 5.1; strains 
and plasmids used in Chapter 3 are listed in Table 5.2.  E. coli strains were grown in LB 
broth or agar (Difco) at 37°C.  P. aeruginosa strains were grown on LB agar plates, and 
overnight cultures were routinely grown in LB broth at 37°C. Overnight P. aeruginosa 
cultures were diluted to an OD600 of ~0.05 in either LB broth or 
morpholinepropanesulfonic acid (MOPS)-buffered minimal medium (50mM MOPS, 
93mM NH4Cl, 43mM NaCl, 2mM KH2PO4) supplemented with 3.5µM FeSO4•7H2O, 
20mM sodium succinate, and 2mM or 0.02mM MgSO4, as indicated.  Chloramphenicol 
was used at a concentration of 30µg/mL for E. coli.  Ampicillin or carbenicillin were 
used at a concentration of 100µg/mL or 300µg/mL for E. coli or P. aeruginosa, 
respectively. 
For growth of P. aeruginosa in medium with added metals in Chapter 3, LB was 
used, which allowed metals to remain in solution.  For the initial screen of lipid A 
modifications in Chapter 3, metal salts were added in the following concentrations: 2mM 
ZnSO4, 0.2mM CdSO4, 0.1mM Ga(III)NO3, 0.2mM FeSO4, 0.1mM CoCl2, 2mM CuSO4, 
2mM MnSO4, and 2mM NiSO4.  The highest concentration of metal that did not 
significantly reduce growth (defined as a >50% reduction in OD600) in liquid medium 
was used, with the exception of Fe3+, for which a lower, more physiologically relevant 
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concentration was used based on concentrations known to induce lipid A modification in 
other organisms (42).    
5.1.2  DNA and RNA preparation 
Before preparing P. aeruginosa genomic DNA from an overnight culture in LB broth, 
two washes with 0.1M NaCl were performed.  Genomic DNA was prepared using the 
Easy-DNA Kit (Invitrogen). Total RNA was extracted from cells grown to an OD600 of 
~0.6 using the RNeasy Mini Kit (Qiagen), according to the manufacturer’s instructions.  
To eliminate residual DNA contamination, total RNA was treated with DNase from the 
RNase-Free DNase Set (Qiagen).  cDNA synthesis was performed using SuperScript III 
Reverse Transcriptase (Invitrogen) according to the manufacturer’s instructions. 
5.1.3  Recombinant DNA methods 
Plasmid DNA was isolated with the QIAprep Spin Miniprep Kit (Qiagen). 
Chromosomal DNA for insertion into plasmid constructs was amplified using either the 
DNA polymerase PfuTurboR (Stratagene) or Takara Ex Taq (Takara).  PCR products 
were separated on an agarose gel and purified using the QIAquick Gel Extraction Kit 
(Qiagen).  All primers were purchased from Integrated DNA Technologies; primers used 
in Chapter 2 are listed in Table 5.3, and those used in Chapter 3 are listed in Table 5.4.  
Restriction endonucleases, T4 DNA ligase, and Antarctic Phosphatase used in this study 
for generation of plasmid constructs were purchased from New England Biolabs and used 
according to the manufacturer’s instructions.  
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5.1.4  Generation of chromosomal gene deletion mutants 
In-frame, markerless gene deletions were generated in P. aeruginosa by 
homologous recombination using the suicide plasmid pEX18Gm (130).  ~1Kb DNA 
fragments flanking the target gene up or downstream were amplified using primers listed 
in Tables 5.3 and 5.4.  An assembly PCR was then carried out to stitch together these 
flanking regions.  Assembly PCR fragments were digested with restriction endonucleases 
EcoRI and HindIII, and ligated into pEX18Gm. The suicide plasmid constructs, pEX18-
lpxTdel and pEX18arnTdel for Chapter 2, and pEX18-eptAdel, pEX18-colRdel, and 
pEX18-colSdel for Chapter 3 were introduced into P. aeruginosa via conjugation with E. 
coli strain SM10 (131).  Deletion mutants were then screened for as described previously 
(130).  Briefly, the gentamycin resistance cassette in pEX18 allows for selection of single 
recombinants, and a sacB gene confers sensitivity to growth on sucrose to allow selection 
of double crossover recombinants. Deletions were confirmed by PCR.   
5.1.5  Plasmid constructs 
 5.1.5.1  Constructs generated in Chapter 2 
Complementation of W3110ΔlpxT was achieved by expressing either lpxTEc or 
lpxTPa in the low-copy number plasmid pWSK29 (132), and PA14ΔlpxT was 
complemented by expressing lpxTPa in the medium-copy number plasmid pEX1.8 (133).  
For generation of both constructs, the lpxTPa gene and RBS were amplified using primers 
PAlpxTF and PAlpxTR (Table S2), digested with EcoRI and HindIII, and ligated into 
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vector cut with the same restriction endonucleases to yield plpxTPa and pEXlpxTPa.  
Constructs were confirmed by sequencing. 
 5.1.5.2  Constructs generated in Chapter 3 
To construct pPA14_39020 (pACeptAPa), pPA14_58610 and pPA14_21210, each gene 
was amplified along with the native RBS and cloned into the medium copy vector 
pACYC184 using EcoRV and SalI restriction endonucleases.  For generation of peptAPa, 
pcolR, ppmrA and pphoP, each gene and its native RBS were amplified and digested with 
EcoRI and HindIII to clone into pEX1.8.  All constructs were confirmed by sequencing.  
The eptAPa and colR genes were amplified along with their native promoters and cloned 
into the medium copy vector pEX1.8 (133) by digestion with SalI or SalI and HindIII, 
respectively, generating peptAnprom and p colRnprom.  For generation of pcolSnprom, the 
colRS promoter was first amplified and cloned into pEX1.8 by digestion with BamHI and 
EcoRI.  The colS coding sequence was then amplified and cloned into pEX1.8 
(containing the colRS promoter) with EcoRI and HindIII.   
5.1.6  Isolation and analysis of labeled lipid A 
Cultures from overnight growth were diluted to an OD600 of ~0.05 in 5mL of fresh 
medium (as indicated) and labeled with 2.5µCi/mL 32Pi (Perkin-Elmer).  Cells were 
harvested at an OD600 of 0.8-1.0, and lipid A was isolated by mild acid hydrolysis as 
previously described (41, 82).  32Pi-labelled lipid A species were spotted on a TLC plate 
at ~5,000 cpm per lane (10,000 cpm for E. coli), and analyzed in a solvent system 
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consisting of 50:50:16:5 (v/v) of chloroform, pyridine, 88% formic acid, and water, 
respectively.  TLC plates were dried, exposed to a phosphor screen overnight and imaged 
using a phosphor-imager (BioRad PMI). 
5.1.7  Large scale lipid A isolation and MALDI-TOF mass spectrometry 
Large scale 250mL-1L cultures were grown at 37°C to an OD600 of ~1.0 in the 
medium indicated.  Lipid A was prepared by mild acid hydrolysis, washed and dissolved 
in chloroform/methanol/water (2:3:1, v/v), as described (83).  Samples were then applied 
to a DEAE cellulose column, washed with chloroform/methanol/water (2:3:1, v/v), and 
eluted as separate fractions using chloroform/methanol/increasing concentrations of 
aqueous ammonium acetate (60mM, 120mM, 240mM, 480mM) (2:3:1, v/v), as described 
previously (83, 134).  Typically, hydrophilic or monophosphorylated species fractionate 
at lower ammonium acetate concentrations (flow-through, wash, 60 or 120mM elution 
fractions), while more hydrophobic, unmodified or phosphate-modified species 
fractionate at the highest concentration, 480mM ammonium acetate.  MALDI-TOF mass 
spectrometry was performed as previously described using a MALDI-TOF/TOF mass 
spectrometer (ABI 4700 Proteomics Analyser) (83).   
5.1.8  ESI and UVPD mass spectrometry 
Lipid A was isolated and prepared as described above for MALDI-TOF analysis. 
All mass spectrometry experiments were executed on a Thermo Scientific Orbitrap Elite 
mass spectrometer (Bremen, Germany) modified to perform ultraviolet photodissociation 
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(UVPD).  The mass spectrometer was equipped with a 193-nm Coherent ExciStar XS 
excimer laser (Santa Clara, CA) and operated in the negative ion mode using a previously 
described set-up (135).  Briefly, solutions containing 1-5 µM lipid A in 50:50 methanol/ 
chloroform were directly infused using an electrospray ionization (ESI) source at a flow 
rate of 3 µl/min. The ESI voltage was set to 4 kV.  UVPD mass spectra were collected 
using 10 laser pulses per spectrum (at 4-5 mJ/pulse) and were interpreted as described 
previously (136).  
5.1.9  Quantitative and Semi-quantitative PCR methods 
Primers for semi-quantitative and quantitative PCR (qPCR) were designed using 
the Primer-BLAST tool (NCBI) and are listed in Tables 5.3 and 5.4.  Semi-quantitative 
PCR performed in Chapter 3 was executed by amplifying cDNA obtained from samples 
cultured in the conditions or with the ppmrA, pphoP and pcolR expression constructs as 
indicated, using primers specific for eptAPa or clpX as a reference gene (84). qPCR was 
performed in a OneStep thermocycler (Applied Biosystems) using Power SYBR Green 
PCR Master Mix (Applied Biosystems), according to the manufacturer’s instructions, as 
described previously (31, 137).   
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5.2      STRAINS, PLASMIDS AND PRIMERS USED 
Table 5.1.  Stains and plasmids used in Chapter 2 
 
Strain or Plasmid Description Reference 
 
Strains 
  
 
E. coli 
 
  
   XL1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F' 
proAB lacIqZΔM15::Tn10 (Tetr)] 
Stratagene 
   W3110 Wild-type, F-I- rph-1 INV(rrnD, rrnE)1 rph-1 E. coli 
Genetic 
Stock 
Center 
(Yale) 
 
   W3110ΔlpxT 
(MST01) 
W3110, ΔlpxT (42) 
 
 
    SM10 thi-1 thr leu tonA lacY supE recA:: 
RP4-2-Tc::Mu (Kanr) 
(de 
Lorenzo 
and 
Timmis, 
1994) 
   
P. aeruginosa 
 
  
   PA14 Wild-type, UCBPP-PA14 (138) 
 
   PA14ΔlpxT PA14, ΔlpxT This study 
 
   PA14ΔarnT PA14, ΔarnT This study 
 
 
 
Plasmids 
 
  
   pWSK29 Low copy vector, T7 and T3 RNA polymerase promoters, (132) 
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Strain or Plasmid Description Reference 
ampicillin resistance  
 
 
 plpxTEc 
 
 
pWSK29 containing E. coli lpxT coding sequence and 
ribosome binding site (RBS) 
 
 
 
(42) 
 
   plpxTPa  pWSK29 containing lpxTPa  coding sequence and RBS 
 
This study 
   pEX18Gm Suicide (gene replacement) vector, oriT+ sacB+, pUC18 
MCS, gentamycin resistance 
 
(130) 
   
pEX18Gm:lpxTdel 
pEX18Gm containing assembly PCR product of 1Kb 
upstream and downstream flanking regions of lpxT coding 
sequence 
 
This study 
   
pEX18Gm:arnTdel 
pEX18Gm containing assembly PCR product of 1Kb 
upstream and downstream flanking regions of arnT coding 
sequence 
 
This study 
   pEX1.8 Medium copy vector, pEX1 carrying ori (P. aeruginosa) as 
1.8-kb 
(133)(132)(131)(129)(127)(126)(125)(124)(123)(122)(5)PstI 
fragment from pRO1614 in StyI site  
 
(133) 
   pEXlpxTPa pEX1.8 containing lpxTPa coding sequence and RBS This study 
 
 
 
 
 
  
Table 5.1 (continued) 
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Table 5.2.  Strains and plasmids used in Chapter 3. 
 
Strain or 
plasmid 
 
Description 
 
Reference 
 
Strains 
  
E. coli   
XL1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F' 
proAB lacIqZΔM15::Tn10 (Tetr)] 
Stratagene 
W3110 Wild-type, F-I- rph-1 INV(rrnD, rrnE)1 rph-1 E. coli 
Genetic 
Stock 
Center 
(Yale) 
W3110ΔeptA 
(CH030) 
W3110, ΔeptA (42) 
BN2 K-12 BW25113, ΔpagP, ΔlpxT, ΔeptA, ΔlpxM (4) 
SM10 thi-1 thr leu tonA lacY supE recA:: 
RP4-2-Tc::Mu (Kanr) 
(131) 
 
P. aeruginosa 
  
PA14 Wild-type, UCBPP-PA14 (138) 
PA14ΔeptAPa PA14, ΔeptAPa This study 
PA14ΔcolR 
PA14ΔcolS 
PA14, ΔcolR 
PA14, ΔcolS 
This study 
This study 
 
 
Plasmids 
  
pACYC184 Low copy-number cloning vector, tetR, camR Novagen 
pPA14_58610 pACYC184 containing PA14_58610 coding sequence 
and RBS 
This study 
pPA14_21210 pACYC184 containing PA14_21210 coding sequence 
and RBS 
This study 
pPA14_39020 
(pACeptAPa) 
pACYC184 containing PA14_39020 (eptAPa) coding 
sequence and RBS 
This study 
plpxEFn pWSK29 containing F. novicida lpxE (49) 
plpxFFn pWSK29 containing F. novicida lpxF (50) 
pEX1.8 Medium copy-number cloning vector, pEX1 carrying ori 
(P. aeruginosa) as 1.8-kb 
(133)(132)(131)(129)(127)(126)(125)(124)(123)(122)(5)
(7)(6)(5)PstI fragment from pRO1614 in StyI site  
(133) 
peptAPa pEX1.8 containing eptAPa coding sequence and RBS This study 
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Strain or 
plasmid 
 
Description 
 
Reference 
peptAnprom pEX1.8 containing eptAPa coding sequence and native 
promoter 
This study 
 
ppmrA 
 
pEX1.8 containing pmrA coding sequence and RBS 
 
This study 
pphoP pEX1.8 containing phoP coding sequence and RBS This study 
pcolR pEX1.8 containing colR coding sequence and RBS This study 
 
 
pcolRnprom 
 
pcolSnprom 
pEX1.8 containing colR coding sequence and native 
promoter 
pEX1.8 containing colS coding sequence and native 
promoter 
This study 
This study 
pEX18Gm Suicide (gene replacement) vector, oriT+ sacB+, pUC18 
MCS, gentamycin resistance 
 
(130) 
pEX18Gm:eptAd
el 
pEX18Gm containing assembly PCR product of 1Kb 
upstream and downstream flanking regions of eptA 
coding sequence 
 
This study 
pEX18Gm:colRd
el 
 
pEX18Gm:col 
Sdel 
pEX18Gm containing assembly PCR product of 1Kb 
upstream and downstream flanking regions of colR 
coding sequence 
pEX18Gm containing assembly PCR product of 1Kb 
upstream and downstream flanking regions of colS 
coding sequence 
 
 
 
 
 
This study 
 
This study 
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Table 5.3.  Primers used in Chapter 2. 
Primer Sequence (5’-3’) Application 
PAlpxTF CTGAATTCATAGGGGGAAACGATTTTATGGATA
ATGC 
 
cloning lpxTPa into 
pWSK29 and pEX1.8 
 
cloning lpxTPa into 
pWSK29 and pEX1.8 
 
PAlpxTR GTCCGCGACTCGGCCTGAAAGCTTGC 
 
lpxTdel-
outF 
GCAGGTAGTAAGCCTCGGCGGAACCTACATG cloning upstream lpxT 
flanking region, 
assembly PCR for lpxT 
deletion 
 
lpxTdel-
outR 
GTGCTGCTCGGCTCCAAGGCGCTGATCG cloning downstream 
lpxT flanking region, 
assembly PCR for lpxT 
deletion 
 
lpxTdel-
inF 
CGATAGGGGGAAACGATTTTATGGATAATGCCT
CTGACTCGGCCTGAGGCCATCC 
 
cloning downstream 
lpxT flanking region 
lpxTdel-
inR 
GGATGGCCTCAGGCCGAGTCAGAGGCATTATCC
ATAAAATCGTTTCCCCCTATCG 
 
cloning upstream lpxT 
flanking region 
arnTdel-
outF 
TGCTCGACTGGCAGCCCAC cloning upstream arnT 
flanking region, 
assembly PCR for arnT 
deletion 
 
Primer Sequence (5’-3’) Application 
arnTdel-
inF 
CAGACCTGGTCGCTGCTGCTGACCTGGTCCTG cloning downstream 
arnT flanking region 
 
arnTdel-
inR 
CAGGATCGCCAGGACCAGGTCAGCAGCAGCGA
CCAGGTCTG 
cloning upstream arnT 
flanking region 
 
PAclpXF AAGAAGGTTCTGGCGGTAGC qPCR analysis of clpX 
expression  PAclpXR ATGTTCTCGACATCCTCGCC 
 
PAarnTF GGCTATGCCAACCTCGACCC qPCR analysis of arnT 
expression 
 
PAarnTR GCGAGGAAGCCCTTGGTCAG 
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PAlpxTF CTGACCTTCGGCTTCATCGT qPCR analysis of lpxT 
expression PAlpxTR TGGAGCGGTCCTTGATTTCC 
 
 
  
 
 
 
  
Table 5.3 (continued) 
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Table 5.4.  Primers used in Chapter 3. 
 
Primer Sequence (5′-3′) Application 
5′ PA14_58610 GCGATATCCCATCGAACGAGGCTA
TCGTGTC 
Used to clone PA14_58610 and 
native RBS into pACYC184 
3′ PA14_58610 CGCGGATCCGCGTCAGCCTTCGTTC
GGCTG 
5′ PA14_21210 CGAGCGATATCTCAGGAGTTGCTTC
AATGGGT 
Used to clone PA14_21210 and 
native RBS into pACYC184 
3′ PA14_21210 CGCGGATCCTCACTGGGCTGCCCTG
GG 
5′ PA14_39020 CGAGCGATATCCAGTGAAGATCCG
TGCCCATG 
Used to clone PA14_39020 
(eptAPa) and native RBS into 
pACYC184 3′ PA14_39020 CGATGTCGACTCAGGAAGCCGGCG
GCTCCT 
5′ PAeptA CGAGCGAATTCCAGTGAAGATCCG
TGCCCATG 
Used to clone eptAPa into 
pEX1.8 
3′ PAeptA CGATAAGCTTTCAGGAAGCCGGCG
GCTCCT 
5′ eptAoutdel GAGAGCTCGAAGCGTCCGACGGTG
TCCAG 
Used to clone upstream eptAPa 
flanking region and for 
assembly PCR to generate  
pEX18Gm:eptAdel 
3′ eptAoutdel GAGGATCCGTCCCGATGAACCACC
CGCA 
Used to clone downstream 
eptAPa flanking region and for 
assembly PCR to generate  
pEX18Gm:eptAdel 
5′ eptAindel GATCCGTGCCCATGTCGAAAGCCG
AGGAAGCGTCTGGCCAGGAG 
Used to clone downstream 
eptAPa flanking region 
3′ eptAindel CTCCTGGCCAGACGCTTCCTCGGCT
TTCGACATGGGCACGGATC 
Used to clone upstream eptAPa 
flanking region 
5′ PAeptAnprom ACGCGTCGACGAAATTCACAGAAG
GGTTTCCCG 
Used to clone eptAPa and native 
promoter (nprom) into pEX1.8 
3′ PAeptAnprom CAAGACGTCGACTCGCCGGGTCGT
ATCAGGAA 
5′ PApmrA CGGAATTCATGAGAATACTGCTGG
CCGAGGACGACCT 
Used to clone pmrA into 
pEX1.8 
3′ PApmrA CCCAAGCTTTCAGGGCGCCGGCTG
GTC 
 
 
 
Table 5.4 (continued) 
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Primer Sequence (5′-3′) Application 
5′ PAphoP CGGAATTCA
TGAAACTGC
TGGTAGTGG
AAGACGAGG 
Used to clone phoP into pEX1.8 
3′ PAphoP CCCAAGCTTTCACCGGCAGCGCTCG
GTG 
5′ PAcolR CGGAATTCATGCGAATACTGGTGGT
CGAAG 
Used to clone colR into pEX1.8 
3′ PAcolR CCCAAGCTTTTATACTCCATTCGGC
TCCTCC 
5′ colRoutdel GTTCTACATGAAGGTGCCCATCGAG
TTCGG 
Used to clone upstream colR 
flanking region and for 
assembly PCR to generate  
pEX18Gm:colRdel 
3′ colRoutdel CGCAGCAGTGGCGCGTTGAACTG Used to clone downstream colR 
flanking region and for 
assembly PCR to generate  
pEX18Gm:colRdel 
5′ colRindel GGACATGCGAATACTGGTGGAGCC
GAATGGAGTATAAGC 
Used to clone downstream colR 
flanking region 
3′ colRindel 
 
5′ colSoutdel 
 
 
 
3′ colSoutdel 
GCTTATACTCCATTCGGCTCCACCA
GTATTCGCATGTCC 
CGGAATTCCGAGGAACAGCCAGGG
GTTGAATGGAC 
 
 
CGGGATCCCACGCGAATACCAAGC
GACTCGAAGGC 
Used to clone upstream colR 
flanking region 
Used to clone upstream colS 
flanking region and for 
assembly PCR to generate  
pEX18Gm:colSdel 
Used to clone downstream colS 
flanking region and for 
assembly PCR to generate  
pEX18Gm:colSdel 
5′ colSindel 
 
GAGGAGCCGAATGGAGTATAAGCT
CGATGTTGCTTGACGA 
Used to clone downstream colS 
flanking region 
3′ colSindel TCGTCAAGCAACATCGAGCTTATAC
TCCATTCGGCTCCTC 
Used to clone upstream colS 
flanking region 
5′ PAcolRnprom ACGCGTCGACCGATCACCAGTTGCT
TGAC 
Used to clone colR and native 
promoter (nprom) into pEX1.8 
 
 
Used to clone colRS  native 
promoter (nprom) into pEX1.8 
 
 
3′ PAcolRnprom 
 
5′ PAcolSnprom 
 
3′ PAcolSnprom 
 
GAGGAGCCGAATGGAGTATAAAAG
CTTGC 
CGCGGATCCCGATCACCAGTTGCTT
GAC 
GCGAATTCGTCCCACTCCTTCGCAG
GA 
Table 5.1 (continued) 
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Primer Sequence (5′-3′) Application 
5′ PAcolS 
 
3′ PAcolS 
 
GCGAATTCATGGAGTATAAGCAGA
GCCTCGC 
GGAAGCTTTCAAGCAACATCGAGT
AAAACTTCGAACC 
Used to clone colS into pEX1.8 
 
5′ qclpX AAGAAGGTTCTGGCGGTAGC qPCR analysis of clpX 
transcription 3′ qclpX ATGTTCTCGACATCCTCGCC 
5′ qeptA TGCCCTGCATGTTCTCCAAC qPCR analysis of eptA 
transcription 3′ qeptA 
 
GATCCTTGCTCTCGCTCAGG 
5′ qarnT GGCTATGCCAACCTCGACCC qPCR analysis of arnT 
transcription 3′ qarnT GCGAGGAAGCCCTTGGTCAG 
  
Table 5.4 (continued) 
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